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Abstract 
 
Quantitative tissue optical spectroscopy has been considered as a promising method for 
clinical diagnosis, owing to its ability to non-invasively give an objective assessment of 
biological tissues at cellular and sub-cellular levels. In spite of recent advances in optics 
and the computational power, not many quantitative tissue optical sensing technologies 
have been translated into clinical practice. In order to translate this technology in the 
clinics, we need to further improve the technology. To name a few, we need accurate and 
rapid quantification method for a real-time diagnostic feedback. Next, we need 
computational methods for complex tissue-optics problems. Also, we need a novel 
approach in probe design for the inaccessible organs. This dissertation focuses on the 
development, verification and validation of theoretical (mathematical and computational) 
and experimental (instrumental) tool set to promote the translation of quantitative tissue 
optical spectroscopy into clinical diagnostic applications.   
For the mathematical tool, a direct-fit photon tissue interaction (DF-PTI) model that 
could rapidly and accurately extract the parameters associated biophysical features was 
developed and validated to characterize the precursor lesions of pancreatic cancer. A 
rapid scattering model on pancreatic tissue reflectance based on principal components 
analysis (PCA) results was also developed. The diagnostic capability of scattering 
properties obtained was demonstrated on an 18-patient data set using a rigorous statistical 
method, which implied the potential of reflectance spectroscopy for real-time detection of 
 xviii 
 
pancreatic cancer. For the computational tool, a ray-traced Monte Carlo (RTMC) 
simulation for the design of fluorescence spectroscopy or imaging system utilizing 
complex optics to probe turbid biological tissues was devised. This new method was 
verified computationally with epithelial tissue models and experimentally using tissue-
simulating optical phantoms. For the instrumental tool, the design and development of 
minimally-invasive diagnostic technologies employing optoelectronic components were 
discussed.  
In this dissertation, we focused on detection of pancreatic cancer, which has the worst 
prognosis among other major cancers. Pancreatic tissues were employed as our model 
system to validate our developed tools. The developed technology and tools can be 
applied to a variety of other human tissue sites to help in the translation of quantitative 
tissue optical sensing in a clinical setting. 
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Chapter 1.                                                                                                                      
Introduction    
1.1 Quantitative Tissue Optical Spectroscopy  
Tissue optical spectroscopy has been considered a promising technique for non-invasive 
assessment of biological tissues in a variety of biomedical applications, including disease 
diagnostics [1] and cellular viability assessment [2]. Essentially, it is analyzing the 
spectral distribution of light that interacts with biological tissues and varies depending on 
tissue morphological (e.g. cellular density/structure), biochemical (e.g. metabolic rate) 
and physiological status (e.g. vascularization/intravascular oxygenation). The main 
sources in the spectral difference are attributed to light scattering or absorption, laser-
induced fluorescence or Raman scattering pattern. Particular instrumental configurations 
for each technique or devices with multi-modal capability [3] have been successfully 
developed and employed to obtain those optical signatures from biological tissues. Not 
only the instrumentation, but also various quantitative methods [4] have been proposed to 
provide a quantitative and objective interpretation of the acquired spectral signal or a 
computational tool for optical probe design.  Compared to the conventional imaging 
techniques currently employed in standard procedure, optical spectroscopy has the 
potential to become a more sensitive tool due to its capability of assessing alteration at a 
cellular and sub-cellular level [5].   
However, even though spectroscopic technologies have been established during the last 
two decades based on recent advances in excitation sources (laser, lamp and LED), fiber 
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optic probes,  sensitive detectors (Intensified Charged Couple Device (ICCD) and  
Electron Multiplying CCD(EMCCD)) and rapid electronics coupled with huge data 
processing capability, they have not been fully translated into clinical practice yet. In this 
dissertation, we focus on developing theoretical and experimental tools to address some 
technical challenges that are a barrier for clinical translation of quantitative optical tissue 
sensing. The developed tool set is intended to provide a comprehensive solution for 
mathematical, computational and instrumental needs in optical tissue sensing techniques 
on in vivo human tissue measurements. Although applications of each developed tool can 
be expanded to a variety of biomedical areas, the developed tools have been verified 
using tissue-simulating optical phantoms and computational epithelial tissue models or 
validated on pancreatic cancer detection from ex vivo human tissue measurements.  
1.2 Basic Principles of Quantitative Tissue Optical Spectroscopy 
1.2.1 Reflectance Spectroscopy 
Reflectance spectroscopy measures the wavelength-dependent intensity of diffusively 
reflected light that undergoes scattering and absorption within biological tissues. An 
incident light on biological tissues is scattered whenever it encounters a mismatch of 
refractive index induced by inhomogeneous cellular structure or extracellular matrix. The 
scattering process is elastic, preserving the energy of the incident light with the same 
frequency; therefore it can occur in a broad wavelength range of incident light. These 
scattering events are also wavelength-dependent; i.e. different cellular or extracellular 
features contribute to the alteration of scattering intensity and angle at a particular 
wavelength range. Thus, the spectral distribution of elastically scattered light indicates 
characteristic features of biological tissues.  
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Absorption events occur when the light is absorbed by endogenous chromophores such as 
oxy- and deoxygenated hemoglobin [6], β-carotine [7] and bilirubin [8] or pigment (e.g. 
melanin) [9]. Each absorber has a unique spectral absorption feature; thus analyzing the 
absorption spectrum enables monitoring of physiological activity and diagnosing of some 
relevant diseases such as jaundice and skin cancer.   
The instrumental setup of reflectance spectroscopy is relatively simple because a broad 
wavelength range can be measured and the intensity of reflectance is much higher than 
other spectroscopic techniques. A halogen lamp is the most commonly used broadband 
light source. An intensified charged-couple device (ICCD) coupled with spectrograph 
[10] or a compact spectrometer device [11] can be used for spectrum recording. As a 
result of recent advances in optoelectronics, white LED has emerged as an alternative, 
small but powerful broadband source [11] and a silicon-photodiode coupled with the 
selected excitation wavelength by monochromator from a broad band lamp source [12] 
has shown the capability of acquiring a wavelength-resolved diffuse reflectance.     
1.2.2 Fluorescence Spectroscopy 
Fluorescence spectroscopy measures fluorescence emitted by specific molecules that 
absorb excitation light. The molecule that absorbs excitation light is activated from the 
ground state to an excited state with a higher electronic energy level. Among a number of 
ways in which the molecules relax to the ground state, fluorescence is the re-emission of 
low energy photons with a longer wavelength than the excitation light. This wavelength 
shift is called the Stokes Shift.  
Fluorescence spectroscopy has been employed to provide biochemical information in 
targeted biological tissues due to its molecular specificity. Molecular specific 
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fluorescence characteristics are the major difference between these and non-
fluorescensing materials. The intrinsic fluorescence is dependent on the concentrations of 
the fluorophores and unique emission spectral characteristics of each fluorophore. The 
measured fluorescence spectrum contains not only this intrinsic fluorescence, but also 
scattering and absorption properties of tissue samples, which can affect fluorescence 
photon propagations. Thus, in order to obtain accurate biochemical information, 
quantitative methods are necessary to uncouple the desired intrinsic fluorescence from 
the measured fluorescence that is a result of mixed events.  
Both endogenous and exogenous fluorophores can be employed in fluorescence 
spectroscopy. Endogenous fluorophores that are naturally fluorescent, include biological 
structures (such as mitochondria and lysosomes), molecules related to a metabolic 
process (such as NAD(P)H and Flavin), extracellular matrix, and proteins (containing 
amino acid, tryptophan and tyrosine) [13]. Targeting these endogenous fluorophores 
enables label-free optical sensing. Exogenous fluorophores are engineered to emit a 
strong fluorescence light with a high quantum yield.  They are commonly used in cell 
imaging to observe spatial localization of specific event. Clinical application of these 
exogenous fluorophores requires a regulatory approval after ensuring clinical safety.   
In a common instrumental setup of fluorescence spectroscopy, a laser source emitting the 
corresponding wavelength to the absorption spectrum of targeted fluorophores is 
employed for excitation. For detection, an optical long- or band- pass filter or a 
monochromater is needed to cut off the excitation laser. Sensitive detectors including, 
ICCDs, EMCCDs, photomultiplier tubes (PMTs) and avalanche photodiodes (APDs) are 
commonly used to capture a relatively weak fluorescence signal with high signal-to-noise 
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ratio.  Optical components are carefully selected such that excitation light does not cause 
the autofluorescence in the optical components that could produce a noise in the target 
fluorescence.   
1.2.3 Quantitative Analysis 
Quantitative analysis of tissue optical spectroscopy aims to uncouple the desired optical 
signal to provide quantitative values of biologically-relevant parameters from the 
undesired background in the measured reflectance and fluorescence. A variety of 
quantitative techniques have been developed to model human tissue reflectance and 
fluorescence, including diffusion approximation (DA) [14], semi-empirical models  [15] 
and Monte Carlo simulations [16]. With a goal to develop theoretical tools for clinical 
translation of tissue optical spectroscopy, this dissertation focuses on advances in the 
semi-empirical model and Monte Carlo simulation.   
Diffusion approximation is an analytical solution to a simplified form of the radiative 
transfer equation (RTE) in a particular situation, in which diffusion can approximate 
overall photon propagations [17]. Although DAs have been commonly used in many 
applications [14, 18, 19], they are inaccurate for tissue interrogation with small source-
detection separation, in which the photon path does not follow a diffusion regime [20]. 
As an alternative approach, forward semi-empirical models have been developed to 
analyze optical spectra obtained by small source-detector separation [15]. Inverse semi-
empirical models have been employed to extract scattering and absorption coefficients in 
media or biophysical parameters [21, 22].  
Monte Carlo simulations are viewed as the “gold standard” method for accurately 
simulating light transport in turbid media such as biological tissues [16, 23]. In MC 
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modeling, light transport is simulated by tracing each photon’s random walk step. Every 
step size, angle and attenuation of individual photons between photon-tissue interactions 
are determined by random sampling based on tissue optical properties. Due to recent 
advances in computing power and speed, MC simulations have been extensively 
employed in various biomedical optics applications to solve both forward and inverse 
problems. In forward problems, optical spectra are estimated [24, 25] and depth-resolved 
optical probes are designed [26, 27]. Inverse models have been used to extract optical 
properties for distinguishing malignant tissue from benign [28, 29] .     
1.3 Clinical Translation of Quantitative Tissue Optical Sensing Technologies 
Not many tissue optical sensing technologies have been successfully commercialized for 
clinical diagnostic applications. The representative example of the device that became a 
standard-of-care in the clinic is the pulse oximeter. The pulse oximeter which is a 
common biophysical monitoring device in the hospital utilizes red and infrared light 
source to non-invasively measure oxygen saturation.  Another example is the 
bilirubinometer, which measures total serum bilirubin level from bilirubin absorption and 
autofluorescence for neonatal jaundice diagnosis [30]. 
Most other technologies have been developed to detect or screen for different types of 
cancers. MelaFind®  (Mela Sciences Inc.) [31] is a FDA- and CE- approved multispectral 
imaging device to aid in detection of early pigmented cutaneous melanoma by providing 
an objective analysis of an irregular mole pattern. VELscope®  (LED Dental Inc.) is also 
a FDA-approved autofluorescence visualization system for oral cancer screening [32]. 
The WavSTAT Optical Biopsy system, developed by Spectra Science Inc., aims to 
become an adjunctive tool to diagnose colon and esophageal cancer during the current 
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endoscopic procedures. The system is based on fluorescence and scattering spectroscopy 
and now has FDA Premarket Approval (PMA). LuViva® , developed by Guided 
Therapeutics, is a multimodal spectroscopic imaging device for cervical cancer screening 
[33] and is currently under FDA PMA review, but is commercially available in other 
countries.  
Some other optical techniques for oral cancer detection are currently undergoing clinical 
trials. The Multispectral Digital Microscopy [34] is a multispectral wide-field 
fluorescence and narrow-band imaging device. The FastEEM4 [35] obtains fluorescence 
spectra excited at different wavelengths, producing fluorescence excitation-emission 
matrices (EEM). 
1.4 Current Technical Challenges 
Accurate and Rapid Quantification Quantitative analysis of the obtained optical signals 
from the designed instrumentation is becoming more essential for clinical diagnostic 
applications. The quantification process can provide an objective assessment compared to 
traditional histology; which can potentially increase diagnostic efficiency and save 
necessary resources required for personnel training. In addition to providing 
diagnostically-relevant information accurately, some applications require a real-time or 
immediate feedback. This ability can maximize the utility of computational quantification 
compared to the traditional histology analysis performed off-site with delayed results    
Computational Tool for More Complex Tissue-Optics Problem Tissue-optics problems in 
quantitative tissue optical sensing can be defined by how the technology obtains a 
targeted diagnostically-relevant parameter in the given tissue optical properties/structure 
and designed optical configuration. Computational modeling based on Monte Carlo 
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simulation plays a critical role in overcoming physical limitations on the actual 
realization of the hardware system and tissue preparation necessary during the tissue-
optics problem solving process. Commercialized devices are handling a relatively simple 
tissue-optics problem that extracts oxy- and deoxy- hemoglobin or bilirubin 
concentrations based on bulk tissue-sensing. In tissue sensing applications for oral, 
cervical, colon and esophageal cancer detection, the model typically builds up two-
layered tissue models consisting of epithelial tissue on top of stroma. However, for some 
clinical applications, tissue-optics problems may be more complex. Thus, there is a 
technical need in the computational tool to address advanced tissue-optics problems.   
Instrumental Innovation for Increasing Accessibility to Confined Areas Most of the 
currently commercially-available techniques introduced in the chapter 1.3 target readily-
accessible sites such as finger, forehead or skin, thus imposing no critical limitation in 
probe design, or sites that can be approached with patients’ cooperation and appropriate 
probe design, such as oral and cervical sites. In case of the WavSTAT Optical Biopsy 
System, the optical probe needs to be delivered via one of the endoscopy working 
channels. Thus, design flexibility is strictly limited to approaches using a fiber-optic 
probe only. Even for some sites allowing only a hollow needle access, such as lung and 
pancreas, single fiber-based spectroscopy and imaging systems [36] compatible with the 
use of a needle have been demonstrated. However, optical fiber technologies have some 
technical drawbacks, including point measurements (lack of spatial information) and 
limited source-detector configurations. 
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1.5 Model System: Pancreatic Cancer  
1.5.1 Background 
The clinical problem for pancreatic cancer is that current diagnostic methods are 
inaccurate and unable to diagnose disease in patients with potentially curable pancreatic 
cancer. Pancreatic adenocarcinoma is the 4th leading cause of cancer deaths in the United 
States. By 2020, pancreatic cancer is projected to become the 2
nd
 leading cause of cancer 
death [37], and over the next 20 years annual deaths from pancreatic cancer are expected 
to increase (the only one of the top five causes of cancer death to do so) until they double 
[38].  
Among the estimated 42,000 patients diagnosed in this country last year, only 7% were 
diagnosed at an early stage [39]. This gives pancreatic cancer the dubious distinction of 
having the highest mortality rate for any solid tumor, with a 5-year survival rate of only 
7%. Among those patients with advanced disease, there are two populations with 
considerable differences in survival. For those with metastatic disease, the 5-year survival 
is 1.8%, compared to 8% for those with localized regional disease (a tumor that is not 
amenable to surgical removal, typically due to involvement of critical blood vessels). 
Since the 5-year survival of patients with surgically resectable (or potentially resectable, 
after neo-adjuvant therapy) disease is 20%, accurate identification of such patients is 
essential to making progress in this disease.   
Current diagnostic methods, including computed tomography (CT), magnetic resonance 
imaging, and endoscopic ultrasound (EUS) have not been able to provide accurate 
diagnosis in early-stage disease, either because of failure identify small lesions or 
inability to accurately differentiate masses as either adenocarcinoma or pancreatitis 
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(inflammation of the pancreas). Intensive efforts to identify and utilize molecular markers 
have not been able to address this diagnostic challenge. 
1.5.2 Key Challenges 
The critical challenge is to provide an accurate tissue diagnosis, which allows rapid 
institution of therapy: either surgery for resectable tumors, neoadjuvant therapy for 
borderline resectable disease, or definitive chemoradiotherapy for patients with localized 
unresectable disease. A recent consensus statement [40] concluded that pretreatment 
tissue diagnosis is mandatory for patients considered for therapy and that the current 
preferred modality for obtaining a tissue diagnosis is endoscopic ultrasound-guided fine-
needle aspiration (EUS-FNA). However, this approach suffers from several limitations as 
discussed below.  
The challenges to accurate characterization of suspect pancreatic neoplasia result from 
the relative inaccessibility of the pancreas given its anatomical location, the non-specific 
nature of symptoms, and the characteristic stromal reaction with intense fibrosis 
associated with both adenocarcinoma and chronic pancreatitis. This similarity 
significantly complicates attempts to differentiate the two similar appearing lesions by 
imaging, even with cytological evaluation of fine-needle aspirates (FNAs). Finding small 
nests of tumor cells in a sea of fibrosis is one major challenge; the differentiation of well-
differentiated cancers from normal tissues, another key challenge is difficult to be 
achieved through cytology. 
 11 
 
 
Figure 1.1 Early and accurate diagnosis of potentially curable pancreatic cancer patients 
is impossible in some cases with current diagnostic methods. The key challenge is 
distinguishing cancer from benign tissues, particularly in case of inflammation (chronic 
pancreatitis). Shown here is a clinical image from pancreatic EUS-FNA (endoscopic 
ultrasound-guided fine-needle aspiration), the diagnostic procedure-of-choice for tissue 
acquisition in suspect pancreatic cancer. It illustrates the lack of specific contrast afforded 
by ultrasound sensing alone [41]. The pancreatic mass is difficult to distinguish, and 
classification relies on cytology, which is often non-diagnostic. 
 
EUS has emerged as an innovative imaging modality to provide access to the pancreas 
for tissue evaluation and is the current diagnostic procedure-of-choice for tissue 
acquisition in suspected pancreatic cancer (Fig. 1.1).  While EUS imaging remains the 
most sensitive test to identify a pancreatic mass, determining whether the mass is benign 
or malignant remains problematic due to reliance on EUS-guided fine needle aspiration 
(FNA) sampling.  Unfortunately, these FNA cytology samples are often non-diagnostic, 
leading to a negative predictive value of only 50-70%, given the high pre-test likelihood 
for cancer among the patients referred for the procedure [42]. For those patients with a 
strong clinical suspicion of pancreatic cancer, laparotomy to obtain tissue for those with 
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unresectable disease or an unnecessary resection for those with a resectable tumor may be 
performed.  
This failure of accurate tissue characterization causes patients to undergo major surgery 
to reveal only benign or inflammatory disease on pathologic examination. The mortality 
of pancreatic surgery is in the range of 2-5% in experienced centers, with major 
morbidity of 20-25% [43]. In one study, as many as 9% of patients were reported to have 
undergone surgery for suspicion of cancer, only to reveal benign disease [44]. Recently, a 
prospective clinical study found that when chronic pancreatitis was present, EUS-FNA 
detected pancreatic adenocarcinoma with a sensitivity of only 54% [45] and a meta-
analysis of 28 clinical studies concluded that EUS-FNA is an inadequate technique to 
rule out malignancy [42]. 
1.6 Optical Techniques for Pancreatic Disease 
A variety of optical spectroscopic and imaging techniques have been attempted on 
cancerous and precancerous pancreatic tissues in animal models and human patients. 
(Fig. 1.2) Optical Coherence Tomography (OCT) has been employed to investigate the 
lesions of the main pancreatic duct in in vivo dog model [46], ex vivo human [47] and in 
vivo human [48] studies. Because it has a long penetration depth, OCT visualizes a 
layered epithelial structure and identifies characteristic patterns in malignant tissues. 
However, its sensitivity for identifying normal tissues is very low; thus OCT is non-
diagnostic in distinguishing normal tissues from other benign lesions. Since OCT images 
cannot display cellular nuclei and organelles clearly due to insufficient resolution and 
providing only a back-scattered pattern of the layers, additional image interpretation by 
an expert is required for an accurate diagnosis. Needle-based confocal fluorescence 
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microscopy coupled with a cathepsin-activatable near-infrared probe (NIRF) has 
demonstrated that molecular imaging could be a sensitive tool for detecting an early stage 
of pancreatic cancer in an in vivo mice model study [49]. There is a regulatory issue of 
using the exogenous NIRF probe for human patients.  Multi-center clinical trials results 
[50] on the needle based confocal laser endomicroscopy has reported a very low 
sensitivity (~ 58%) to detect pancreatic cystic neoplasms, probably because of the 
necessity of subjective interpretation of low resolution images. Non-linear optical 
microscopy has been proposed as a label-free and real-time method to characterize 
pancreatic histology at a cellular level [51]. However, the bulky and expensive 
instrumentation set up make it difficult to be translated into clinical practice.  Although 
diffuse optical tomography (DOT) has been developed and showed feasibility in porcine 
tissue [52], it is still at the development stage and requires further technical and 
biological validations.   
Optical scattering markers in duodenal mucosa have been investigated to predict the 
malignant changes in the pancreas based on the field effect theory [53]. A recent in vivo 
human study employing polarization gating spectroscopy [54] has revealed the diagnostic 
potential of detecting the increase in blood supply surrounding malignant tissues for 
identifying pancreatic cancer according to the field effect. However, the technology has 
critical limitations in distinguishing normal tissues from inflammatory tissues, which is 
currently the unmet clinical need.  Previous ex vivo studies [22, 55-57] performed in our 
lab have shown that reflectance and fluorescence optical spectroscopy has potential as a 
label-free, rapid, quantitative, compact, cost-effective optical biopsy tool to address 
current clinical needs. None of the optical techniques introduced here except optical 
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spectroscopy are yet ready for clinical translation because of technical immaturity, 
insufficient clinical efficacy, inability to address critical unmet needs in a clinic or 
instrumental/cost limitations. However, many technical issues still remain to be addressed 
in translating optical spectroscopy into in vivo human study. 
 
Figure 1.2 Types of optical techniques developed for pancreatic cancer diagnostics (A) 
left: OCT probe inserted inside Endoscopic retrograde cholangiopancreatography (ERCP) 
[47] right : obtained OCT images for normal (left) and tumor-involved main pancreatic 
duct sections [48]  (B) needle based confocal laser endomicroscopy images on intraductal 
papillary mucinous neoplasm [50] (C) Near infrared probed confocal imaging in mouse 
model [49] (D) Nonlinear optical microscopy images (left) on normal rat pancreas 
compared to hematoxylin and eosin image (right)(E) Polarization gating spectroscopy 
probing duodenal mucosa in endoscopy channel [54] (F) Diffuse optical tomography 
technique in duodenoscope [52] 
 
 
(D)(C)
(A) (B)
(E)
(F)
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1.7 Dissertation Objectives 
The main objective of this dissertation is to develop theoretical (mathematical and   
computational) and experimental (i.e. instrumental) tools to fill the gap between the 
current technology and the desired technology for human tissue optical sensing. Specific 
Aim 1 is focused on two different mathematical models for rapid and accurate 
quantification of human pancreatic tissue reflectance and fluorescence. Aim 2 involves 
the development of a new computational simulation method to evaluate fluorescence 
spectroscopy or imaging system in turbid media. Aim 3 concerns the instrumental design 
of optoelectronic microprobe that can be inserted into a hollow needle (~ 1 mm diameter) 
for optical sensing in a very limited space which even an endoscopic channel is unable to 
gain access.    
Specific Aim 1: To develop and validate a mathematical model for rapid and 
accurate quantitative analysis of ex vivo human pancreatic tissues. Two different 
mathematical models will be developed to extract parameters associated with biophysical 
features or scattering properties in order to rapidly and accurately assess human 
pancreatic tissues freshly excised during the surgery.  
Specific Aim 2: To devise and verify a computational method for the assessment or 
design of fluorescence spectroscopy or imaging system utilizing complex optics to 
probe turbid biological tissues. A new computational method will be developed by 
combining the conventional optical design software and the gold-standard Monte Carlo 
method, and will be verified computationally and experimentally.   
Specific Aim 3: To design and fabricate a prototype of an optoelectronic microprobe 
for an accurate diagnosis of pancreatic cancer during the EUS-FNA procedure. 
Microfabrication technology will be employed to fabricate a prototype board assembled 
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with miniaturized die-level optoelectronic component, and their overall performance and 
optical sensing feasibility will be tested using the calibrated tissue optical phantoms. 
1.8 Dissertation Overview 
Chapter 2 describes the development and validation of a rapid semi-empirical model, 
called the Direct Fit Photon Tissue Interaction Model (DF-PTI), for quantitative 
characterization of precursor lesions of pancreatic cancer. The DF-PTI model extracts 
parameters associated with morphological and biochemical features from the first-ever 
optical spectroscopic measurement on human pancreatic pre-cancerous tissues. 
Chapter 3 describes the development and validation of a simple scattering model of 
steady-state reflectance to evaluate the potential for real-time cancer detection using 
reflectance spectroscopy. The principal component analysis reveals that reflectance-only 
data has a e diagnostic performance comparable to that of the multi-modal approach. The 
simple and rapid scattering model is employed to analyze steady-state reflectance 
obtained from freshly excised human pancreatic tissues. The diagnostic power of 
scattering properties of pancreatic tissue in distinguishing malignant from non-malignant 
tissues will be evaluated utilizing a rigorous tissue classification algorithm. 
Chapter 4 describes the basic principle of ray-traced Monte Carlo simulation method and 
its verification on computational tissue models and two-layered optical tissue-simulating 
phantoms.   
Chapter 5 describes the design, fabrication, assembly, characterization and feasibility 
tests on the first prototype of an optoelectronic microprobe that is compatible with a 
hollow needle for accurate in vivo pancreatic cancer detection. 
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Chapter 6 summarizes and concludes the dissertation with a statement of its scientific 
contributions and a discussion of future works.  
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Chapter 2.                                                                                                                   
Mathematical Model on Diffuse Reflectance of Pancreatic Pre-Cancerous Tissues 
2.1 Introduction 
Pancreatic adenocarcinoma, the 4
th
 leading cause of cancer death in the United States 
with a five-year survival rate of less than 7%, is often detected at late-stages of 
development when treatment is ineffective [58]. Intraductal papillary mucinous neoplasm 
(IPMN, Fig. 2.1) is a precursor lesion of pancreatic cancer, characterized by an 
intraductal proliferation of neoplastic cells with mucin production [59].  
IPMN diagnosis, which could offer an opportunity to treat patients before they develop a 
potentially incurable pancreatic malignancy, may be challenging; identifying those IPMN 
with progression to malignancy remains an unmet medical need. Of the main imaging 
modalities employed to detect IPMN (computed tomography, endoscopic retrograde 
cholangiopancreatography, magnetic resonance cholangiopancreatography, and 
endoscopic ultrasonography (EUS)), EUS offers the highest resolution [60] and enables a 
cytologic diagnosis of IPMN via fine-needle aspiration (EUS-FNA). However, the 
sensitivity of EUS-FNA cytology diagnosis is low (44-75%) [61, 62] and the technique 
suffers from a steep learning curve and high inter-operator variability [63]. Thus, the 
effectiveness of identifying cancer precursor lesions such as IPMN could be improved by 
developing a more sensitive and quantitative detection method. 
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Figure 2.1 Representative histological images of (A) normal pancreatic ductal tissue 
(BPC: benign pancreatic cell), (B) IPMN (MPC: malignant pancreatic cell with enlarged 
nuclei), and (C) pancreatic adenocarcinoma (AC with enlarged nuclei). The nuclei and 
stroma have been stained purple (hematoxylin stain) and pink (eosin stain), respectively. 
Note that IPMN and AC tissues have similar biophysical features, including nuclear 
enlargement and abundant collagen surrounding cells, relative to normal tissues. These 
features can be analyzed by quantitative multimodal optical spectroscopy. 
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Optical spectroscopy has shown promise as a potential diagnostic tool for pre-cancer 
detection in various human tissues, including the cervix [64], the colon [65] and the 
breast [7]. Advantages of optical spectroscopy compared to current imaging modalities 
(listed above) include quantifying tissue morphological and biochemical alterations 
occurring at the molecular and cellular levels during neoplastic progression [66] and 
clinical compatibility with EUS-FNA procedures [67]. Previously, our group successfully 
distinguished human pancreatic diseases, including pancreatic adenocarcinoma (AC) and 
chronic pancreatitis, from normal tissues with multimodal optical spectroscopy and a 
mathematical photon-tissue interaction (PTI) model [22, 55, 56, 68].  
Here, we report the first, to our knowledge, optical spectroscopic (reflectance and   
fluorescence) measurements from human pancreatic malignant precursor, IPMN. Because 
the study employed tissues obtained surgically, typically from patients with advanced 
disease, the opportunity to study IPMN (a cancer precursor) in patients was limited. For 
freshly excised pancreatic tissues (Fig. 2.1), we developed quantitative tissue-optics 
models to assess the biophysical similarities and differences between normal tissues, 
IPMN, and AC tissues. 
2.2 Experimental methods 
2.2.1 Instrumentation 
A Reflectance and Fluorescence Lifetime Spectrometer (RFLS) [10], was employed to 
obtain reflectance and fluorescence spectra of human pancreatic tissues. A tungsten 
halogen lamp (HL 2000FHSA, Ocean Optics) provided white light (400-750 nm) for 
reflectance measurements; a pulsed laser at 355 nm (PNV001525-140, JDS Uniphase) 
provided fluorescence excitation light. Lamp and laser light was delivered to tissue via 
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two separate optical fibers with core diameters of 600 μm. Tissue reflectance and 
fluorescence light were collected by a third identical fiber and delivered to the detectors. 
Collected light was passed to a spectrograph (MS 125, Oriel Instruments) coupled to an 
intensified charge-coupled device camera (ICCD 2063, Andor Technology) to detect 
tissue reflectance (400-750 nm) and fluorescence (360-700 nm). The RFLS also 
measured time-resolved fluorescence decays, which are not discussed here. Data 
aquisition time for each modality was less than 1 s. All measured spectra were 
background subtracted, corrected, and normalized as in [10].   
2.2.2 Human studies and data set 
The study was approved by the Institutional Review Board of the Univ. of Michigan (U 
of M) Medical Center. Informed written consent was obtained from each patient. Optical 
data were acquired from freshly-excised human pancreas within 30 minutes of resection 
during pancreatic surgery. Measurements were taken at up to 10 sites on each tissue 
specimen, depending on specimen size. At each site, two reflectance and two 
fluorescence spectra were collected. For each tissue site, immediately after optical 
measurements were acquired, the site was biopsied by a clinical pathologist for 
histopathological tissue analysis to confirm diagnosis.   
Table 2.1 Numbers of patients and analyzed tissue sites for each tissue type 
Tissue Type Number of Patients 
Number of Analyzed Tissue Sites  
Reflectance Fluorescence 
Normal 3 11  11  
IPMN 2 8 5  
AC 4 17  17  
 
 22 
 
Table 2.1 summarizes the study. Two measurements on each site were averaged for 
analysis. The IPMN diagnoses were “IPMN with moderate dysplasia,” as shown in Fig. 
1. The 22 normal and 33 AC reflectance and fluorescence spectra from 11 and 17 sites, 
respectively, used for comparison with the IPMN data, were reported previously [68]. For 
one IPMN patient, fluorescence spectra were not recorded due to misalignment. Among 
18 measured IPMN reflectance spectra from 9 sites, two spectra from one site were 
excluded by the exclusion criteria R550 nm/R650 nm < 0.1 [12, 14] due to excessive blood 
absorption.  
2.2.3 Direct Fit PTI model for steady-state reflectance and fluorescence  
A PTI model for reflectance and fluorescence spectra was reported [22, 68]. The model 
employed a semi-empirical reflectance equation to extract absorption- and scattering-
related tissue parameters from measured reflectance spectra. The empirical model was 
described as a function of the tissue scattering coefficient (related to the cellular nuclear 
diameter L, nuclear refractive index ns, and cellular density [Cell]) and the tissue 
absorption coefficient (related to a linear combination of oxygenated [oxy-Hb] and 
deoxygenated [deoxy-Hb] hemoglobin concentration). In this model, nuclear diameter, 
total hemoglobin concentration and oxygen saturation were freely varied for fitting with 
remaining variables fixed. 
Here, a Direct Fit PTI (DF-PTI) model was developed and employed with seven main 
modifications to the previous model [12] : 1) to improve fit quality at all wavelengths, the 
semi-empirical model was fit directly to the measured data without a “canonical normal” 
spectrum, 2) the wavelength range for fitting was expanded from 700 nm to 750 nm to 
more accurately account for the effect of cellular nuclear size and refractive index on 
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spectrum shape [69], 3) the cost function was minimized with a nonlinear least-squares 
iterative algorithm, 4) bilirubin [Bilirubin] was added as an absorber [67], 5) collagen 
concentration [Collagen] and cellular density [Cell] were freely varied, 6) nuclear 
refractive index was freely varied, as the refractive index is related to tissue malignancy 
[70], and 7)  the mean vessel radius Rv was freely varied [71]. In the original PTI model, 
mean vessel radius was fixed at 7 µm and the absorption coefficient of whole blood was 
employed for the vessel packaging correction factor. In the DF-PTI model, the blood 
absorption in the capillary network was modeled with a varying vessel radius size and 
blood volume fraction (ρ) [72].  The ranges of varied tissue parameters employed in the 
DF-PTI model are shown in Table 2.2  
Table 2.2 Ranges of all the varied tissue parameters in the DF-PTI reflectance model 
 
For each tissue measurement, the scattering coefficient calculated via the best DF-PTI 
reflectance fit was employed to correct the corresponding fluorescence spectrum for 
attenuation [22]. As measurements were ex vivo and local blood content could vary over 
time, only the extracted scattering, and not absorption, coefficient was employed to 
calculate intrinsic fluorescence, while hemoglobin and bilirubin concentrations were 
varied when calculating intrinsic fluorescence. The resulting intrinsic fluorescence 
spectra were fit to a linear combination of basis spectra of three endogenous tissue 
Parameters L ns [Cell] [Collagen] 
[oxy-Hb] 
[deoxy-
Hb] 
Rv ρ [Bilirubin] 
Min. Value 8 μm 1.37 5.6×107 (/cm3) 1.0×106 (/cm3) 0 µM 7µm 0 0  µM 
Max. Value 14 μm 1.40 8.4×107 (/cm3) 1.0×107 (/cm3) 50  µM 20µm 0.15 40  µM 
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fluorophores: nicotinamide adenine dinucleotide (NADH, 450-500 nm emission peak), 
flavin adenine dinucleotide (FAD, 500-600 emission peak ) and collagen (400-450 
emission peak) [22]. The best fit provided the fractional contribution of each fluorophore 
to the intrinsic fluorescence.  
2.3 Results and Discussion 
2.3.1 Comparison between PTI model and DF-PTI model  
Figure 2.2 compares the fitting results of the (A) PTI model and the (B) DF-PTI model. 
Analyzed reflectance spectra were collected from a tissue site confirmed to be IPMN 
with moderate-grade dysplasia. In the wavelength range 450–530 nm, which is related to 
nuclei scattering [55], the DF-PTI showed improved fit accuracy compared to the PTI 
model. In the Soret (400 – 420 nm) and alpha/beta bands (500 – 540 nm) of hemoglobin 
absorption, the DF-PTI showed improved fit accuracy compared to the PTI model. In the 
slope after 620 nm (attributed to tissue scattering) [67], the DF-PTI showed improved fit 
accuracy compared to the PTI model.  The mean percent error of the DF-PTI model was 
less than 2 %, which showed a better accuracy than the PTI (~8%). The execution time 
for DF-PTI model fitting procedure on each site was less than 2 seconds, reduced from > 
30 seconds for the PTI model. 
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Figure 2.2 Representative model fitting results on measured IPMN reflectance spectra 
using (A) the original PTI model, and (B) the developed DF-PTI model.  Solid green 
lines indicate measurement IPMN reflectance and dotted red lines indicate each model 
fit. 
2.3.2 Reflectance analysis  
Figure 2.3 (A) shows the average of all normalized reflectance spectra from human 
pancreatic tissues: normal, IPMN with moderate dysplasia, and AC tissues. The features 
in the 400-440 nm and 540-580 nm ranges were attributed mainly to hemoglobin 
absorption. The higher reflectance in the 450-530 nm range in IPMN and AC sites was 
attributed to the cellular density and nuclear size [22, 68]. Figure 2.3 (B) shows 
wavelength-dependent standard errors of the mean spectra for each tissue type. It is noted 
that standard errors are greatest in the wavelength range related hemoglobin absorption. 
Figure 2.3 (C) shows a representative PTI model fit to IPMN reflectance. Mean percent 
error between measured data and fit for all the measurements was less than 5% in the 
range 450-750 nm. The mean values of extracted nuclear diameters and refractive indices 
from IPMN measurements were larger than those from normal tissues (Table 2.3) 
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Figure 2.3 Quantitative analysis of measured reflectance spectra can distinguish IPMN 
and AC from normal pancreas. (A) Mean of normalized reflectance spectra obtained from 
human pancreatic normal tissues, IPMN with moderate dysplasia, and AC. (B) 
Wavelength-dependent standard error bars of mean measured spectra for each tissue type. 
(C) Representative PTI model fit for IPMN reflectance. 
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The mean extracted nuclear sizes are consistent with histology (Fig. 2.1), indicating 
nuclear enlargement both in IPMN and AC relative to normal pancreas. Additionally, the 
ratio of the extracted nuclear size of AC to normal tissue (11.64/8.89 = 1.30) is consistent 
with the previously reported nuclear dilation factor L/L0 (1.27 ± 0.01) [68]. The result for 
mean extracted refractive index of normal pancreas (1.372) was consistent with previous 
reports [22, 68]. The extracted nuclear refractive indices of IPMN and AC were larger 
than that of normal pancreas. This finding is consistent with studies reporting that 
dysplastic cell nuclei have larger refractive indices than normal nuclei due to the higher 
DNA content and concentrations of nucleic acids in dysplastic cells relative to normal 
cells [70, 73].    
 Here, variations in local tissue blood content arising from the experimental protocol 
(tissue dissection prior to optical measurement) preclude the reporting of tissue 
absorption-related parameters. We note that mean estimated vessel radii were 11 to 13 
µm for all tissue types. Larger estimated vessel radius (compared to previously employed 
7 µm), with the inclusion of fractional blood volume, produced more accurate fits within 
the Soret absorption band. 
Table 2.3 Extracted parameters related to tissue scattering for each tissue type 
Tissue Type Nuclear diameter  Refractive index  Cell Density  Collagen Density 
Normal 8.89 ± 0.13 μm 1.372 ± 0.002 8.07 ± 0.12 ×107/cm3 1.28 ± 0.16 ×106/cm3 
IPMN 11.50 ± 0.88 μm 1.394 ± 0.004 7.15 ± 0.09 ×107/cm3 6.15 ± 1.56 ×106/cm3 
AC 11.64 ± 0.37 μm 1.396 ± 0.002 7.21 ± 0.09 ×107/cm3 8.58 ± 0.62 ×106/cm3 
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Figure 2.4 Quantitative analysis of measured fluorescence spectra can distinguish IPMN 
and AC from normal pancreas. (A) Mean of normalized fluorescence spectra obtained 
from human pancreatic normal tissues, IPMN with moderate dysplasia, and AC. (B) 
Wavelength-dependent standard error of mean spectra for each tissue type. (C) 
Representative PTI model fit for IPMN intrinsic fluorescence 
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2.3.3 Fluorescence analysis  
Figure 2.4 (A) shows the average of all normalized fluorescence spectra from human 
pancreatic normal, IPMN, and AC tissues. Fluorescence spectra included contributions 
from intracellular NADH and FAD, and from stromal collagen, with emission peaks 
around 470 nm, 540 nm, and 430 nm, respectively. Although measured fluorescence 
spectra were attenuated by hemoglobin absorption, notable spectral differences between 
normal and diseased pancreas were apparent. Figure 2.4 (B) shows the wavelength-
dependant standard error of the mean spectra for each tissue type, with higher variation in 
the wavelength band attributed to hemoglobin absorption. Intrinsic fluorescence was 
calculated from measured fluorescence (Fig. 2.4 (C)). Mean percent error of fitting 
intrinsic fluorescence in the range 400-550 nm was under 7%.  
The extracted percentage contribution from collagen emission to the intrinsic 
fluorescence for normal, IPMN, and AC tissues were 45.4 ± 7.3 %, 92.2 ± 3.4 % and 76.1 
± 5.4 %, respectively. The collagen contribution to the intrinsic tissue fluorescence was 
greater for IPMN and AC tissues than for normal pancreas. This result is consistent with 
histological findings (Fig. 2.1), which indicate a collagen-rich stroma in IPMN and AC 
relative to normal pancreas. The increase of extracellular collagen content in IPMN and 
AC relative to normal pancreas arises from a fibrotic response during disease 
development, with collagen surrounding IPMN being more mature and with denser 
organization, since it is formed more slowly than collagen surrounding pancreatic AC, 
which is immature and newly formed in the process of tumor-induced desmoplasia 
(abundant fibrotic stroma) [74]. 
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2.4 Conclusion 
The DF-PTI model was developed and employed to quantitatively analyze reflectance 
spectra from pre-cancerous human pancreatic tissues. The DF-PTI model is faster and fits 
measured data more accurately (over a wider wavelength range) than previously-reported 
models.  
The analysis results suggest that multimodal tissue optical spectroscopy coupled with 
quantitative tissue-optics models can characterize intraductal papillary mucinous 
neoplasm (IPMN), a cancer precursor in human pancreatic tissues. The analysis 
developed here assessed parameters associated with cellular nuclear size, nuclear 
refractive index, and tissue collagen content, and the results were consistent with known 
histopathology for these tissues. 
Parameters extracted from model fits to reflectance and fluorescence data distinguished 
IPMN tissues from normal pancreas and closely associated IPMN tissues with pancreatic 
cancers. Thus, optical characterization of IPMN tissues, which have similar optical 
scattering properties to adenocarcinoma, could enable early clinical intervention, 
including follow-up examinations to monitor progression to malignancy with the goal to 
intervene prior to development of an incurable pancreatic cancer.  
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Chapter 3.                                                                                                                            
Quantitative Analysis for Real-time Pancreatic Cancer Detection 
3.1  Introduction  
For a minimally-invasive and accurate diagnostic tool for pancreatic cancer detection, a 
multimodal optical spectroscopy was previously developed to demonstrate the first 
optical spectroscopic assessment on a mouse xenograft model and freshly excised human 
pancreatic tissues [55]. Also, a mathematical model called photon tissue interaction (PTI) 
model based on a semi-empirical model was previously developed to provide the first 
quantitative link between pancreatic tissues histology and the obtained reflectance and 
fluorescence spectra [22]. For accurate diagnostics, tissue classification algorithm based 
on a linear discriminant analysis employing the spectral area and ratio, was created on the 
dataset of nine patients consisting of 96 fluorescence and reflectance measurements: 33 
measurements from 17 adenocarcinoma sites, 41 from 22 pancreatitis sites and 22 from 
11 normal sites [56]. The PTI model has been validated on the same dataset to reveal that 
the extracted biophysically-relevant parameters such as nuclear enlargement factor and 
collagen fluorescence contribution can distinguish adenocarcinoma from pancreatitis and 
normal tissue with statistical significance [57].  
However, the previous studies suffer from a limited patient population, which made it 
difficult to draw a convincing conclusion about the diagnostic accuracy of optical 
spectroscopy. Furthermore, multiple sites were measured per patient, leading to intra-
patient correlation. Thus, a more statistically-rigorous classification algorithm is required 
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on a larger patient number to more accurately assess the diagnostic accuracy. Using that 
tissue classification algorithm, a different analysis model could be tested for accurate and 
rapid quantification method for real-time pancreatic detection. In this chapter, we present 
tissue classification results employing a principal component analysis on both reflectance 
and fluorescence data obtained from 18 patients. The results show that reflectance data 
only has the classification performance comparable to the combination of the reflectance 
and fluorescence spectroscopy. Based on this finding, we further introduce the scattering 
model to analyze pancreatic tissue reflectance and describe the diagnostic capabilities of 
scattering properties of human pancreatic tissues.   
3.2 Materials and Methods  
3.2.1 Instrumentation 
A clinically-compatible reflectance spectroscopy and fluorescence system [10] was 
employed in the study. In this work, we have focused on characterizing pancreatic tissue 
via reflectance spectroscopy. Also, the detailed descriptions about a setup for 
fluorescence spectroscopy and data processing can be found in the literature [75].     
With our focus on reflectance, the instrumental set up for reflectance measurements 
consisted of a tungsten-halogen lamp (HL 2000FHSA, Ocean Optics, Dunedin, FL) as a 
broadband light source, a spectrograph (MS 125, Oriel Instruments, Stratford, CT) 
coupled with an ICCD (2063 Andor Technology, Belfast, Northern Ireland) for recording 
spectrum, and a hand-held optical probe to deliver and collect light to and from 
pancreatic tissues (Fig 3.1 (a))[55]. The probe had two multi-mode optical fibers for 
source and detector (600 µm core diameter and 660 µm center-to-center spacing). Spectra 
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were collected in the range from 460 nm to 760 nm with 0.7 nm spectral resolution. 
Acquisition time for one spectrum was less than 0.5 seconds.   
To correct measured tissue reflectance for instrument artifacts, measured spectrum 
RTISSUE_meas(λ) was background-subtracted and calibrated for spectral response of the 
system. The dark background RBG_meas(λ), was measured prior to every reflectance 
acquisition. The spectral response, RREF_meas(λ) was acquired by placing a probe at fixed 
distance (6 mm) from a 50% diffuse reflectance Spectralon standard (SRS-50-010, 
Labsphere, North Sutton, NH) before the surgery began. Known reflectance of the diffuse 
standard, RREF_known(λ), was multiplied to the corrected spectrum, generating a relative 
tissue reflectance to the standard, RTISSUE (λ) (Eg.3.1) .  
_ _
_
_ _
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Figure 3.1 (A) Schematic of the fiber-optic-based instrument and its advantages for 
clinical usage. The instrument has a compact configuration inside a clinically-compatible 
mobile cart. Acquisition time is less than 0.5 s, enabling real-time analysis without 
patients’ motion artifact. Unlike aspiration cytology, non-invasive optical measurement 
enables to examine intact tissues with the interrogation volume of 1 mm
3
, which is a 
typical FNA volume. Smaller fiber optic probe can be employed to be compatible with 
the EUS-FNA needle. All technical feature makes reflectance spectroscopy suitable for a 
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real-time optical biopsy tool (B) Mean measured reflectance spectra (solid- colored lines, 
left y-axis) for three pancreatic tissue types using the instrument and molar extinction 
coefficients of oxygenated and deoxygenated hemoglobin (solid-gray and dashed-gray, 
right y axis). Error bars for the mean spectra represent the standard error. Blue-shaded 
region indicates a wavelength window (> 630 nm) that is relatively independent from 
tissue absorption (mainly due to hemoglobin) and show a distinctive difference between 
pancreatic tissue types. Thus, this wavelength range is of our interest for tissue scattering 
analysis. 
3.2.2 Human Study  
Reflectance data was collected from 18 patients who underwent pancreatic surgery (age 
36 to 79, mean ± SD = 62.9 ± 11.3; 5 males and 13 females). Study was approved by the 
Institutional Review Board of University of Michigan and consent was acquired from the 
patients prior to all measurements. Within 30 minutes after pancreas was excision, a 
pathologist accessed pancreatic tissue sites for optical measurement. The end of the fiber 
optic probe was placed in contact with the tissues sites and two measurements were 
performed sequentially. Depending on the sample, up to 10 sites were measured. 
Immediately after data acquisition, the pathologist collected a biopsy from the same site. 
Biopsied tissue was approximately 3-5 mm in diameter which corresponds to optical 
interrogation volume of ~ 1 mm
3
 in this study. Obtained biopsies were fixed in formalin, 
paraffin-embedded, sectioned and stained with hematoxylin and eosin for histologic 
examination.  Histology confirmed 39 normal sites from 9 patients, 34 pancreatitis sites 
from 9 patient and 32 adenocarcinoma sites from 8 patients were analyzed. Some 
different tissue types were measured from the same patient. Of the total of 117 sites, 12 
sites were excluded due to excessive blood content or low SNR. 
3.2.3 Principal Component Analysis  
To investigate the diagnostic capability of reflectance and florescence data for classifying 
malignant tissue from non-malignant tissues, a Principle Component Analysis (PCA) 
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model was employed to extract the principal components from each reflectance and 
fluorescence spectrum. The inputs to the PCA code were the corrected and normalized 
reflectance and fluorescence spectra. The PCA code was written in MATLAB using a 
native MATLAB function.  
3.2.4 Rapid and Simple Scattering Model for Reflectance Analysis 
Although the reflectance spectra were acquired in the wavelength range from 460 to 760 
nm, only the range from 630 to 760 nm was analyzed to extract tissue scattering 
parameters. It’s because that the absorption by major chromophores in human tissues is 
negligible and the acquired spectra of each pancreatic tissue type showed a distinctive 
difference (Fig. 3.1(b)) in this range. Without absorption, it was observed there was a 
linear relationship between the reflectance and the reduced scattering coefficient [15]. 
Thus, tissue reflectance was simply modeled using (Eq. 3.2).  
0'TISSUE sR a a                                                                                       Equation 3.2 
 Here, the coefficients of a and a0 values were obtained by a linear fitting of measured 
reflectance values on manufactured tissue-simulating phantoms described in detail in Fig. 
3.2. The reduced scattering coefficients of manufactured phantoms ranged from 5 to 20 
cm
-1
 within a typical range for human tissues [76]. The wavelength-resolved reduced 
scattering coefficient was modeled using power law dependence on the wavelength (Eq 
3.3), which is widely accepted in biomedical optics [76, 77].     
0 0' ( ) ' ( )( / )s s
      
                                                                     Equation 3.3 
µ’s(λ0) was the reduced scattering coefficient value at the reference wavelength, 630nm 
and the exponent γ was defined as scattering power, which was known to be related to 
 36 
 
average scatterer size [78, 79]. This simple scattering model based on power law 
dependence fitted the corrected tissue reflectance to extract two scattering parameters 
µ’s(630) and γ.  The fitting range of µ’s(630 nm) was limited to a typical value of human 
tissues and the scattering power γ was 0.2 < γ <4.0 from theoretical [80] and 
experimental [81] results. A nonlinear least squares algorithm was employed for rapid 
fitting procedures and the process time per one spectrum was less than a hundred 
milliseconds. 
3.2.5 Phantom Calibration  
Solid phantoms were made using an agarose (161-3101, Bio-Rad Laboratories, Hercules, 
CA) according to the literature published recipe [76]. Briefly, 0.2 g of agarose powder 
was added to boiling DI water (20mL) and dissolved. The, the mixture was cooled at 
room temperature until ~ 80 ˚C. Before reaching 60 ˚C, either 0.4, 0.8, 1.2 and 1.6 mLs 
of 20% Intralipid (I141, Sigma-Aldrich, St. Louis, MO) were added to different agarose 
solutions as a scattering agent and thoroughly stirred until the solution was homogeneous. 
At 40 ˚C, the mixed solution was transferred into a glass beaker to solidify, which took 
about two hours. Resulting phantom is a solid cylinder with a diameter of 40 cm and a 
depth of 3 cm.  
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Figure 3.2 Linear relationship (R
2
 = 0.99) between the measured relative reflectance and 
reduced scattering coefficients of the scattering phantoms with no absorbers. Error bars 
present standard deviation. The range of reduced scattering coefficients, from 10 to 20 
cm
-1
 is relevant to human pancreatic tissues. 
 
Reduced scattering coefficient of each phantom was determined by an integrating sphere 
(RT-60-SF, Labsphere, North Sutton, NH) setup and an inverse adding-doubling 
algorithm [82]. Reduced scattering coefficients at 630nm of four phantoms were 
calculated to be 3.6, 6.7, 12.0 and 19.2 cm
-1
, respectively. Manufactured phantoms were 
also measured by reflectance spectroscopy. Four sites were measured on each phantom. 
Measured phantom spectra were background-subtracted and calibrated. Linear regression 
was performed on reflectance data with the corresponding reduced scattering coefficients 
to determine the coefficients of a and a0 
3.2.6 Statistical Analysis and Performance Metrics  
For the initial comparison, a two-sided Wilcoxon rank sum test was performed to assess 
the ability of each scattering parameter to discriminate three tissue types. To evaluate 
their classification ability in a more statistically-rigorous way, a multinomial logistic 
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regression using Generalized Estimating Equations (GEE) model [83, 84] was employed 
in a “leave-two-patients-out” cross-validation method.  The GEE accounted for the 
correlation among sites measured from the same patients [85, 86]. In the cross validation, 
dataset was split into 9 training sets and testing sets including 16 patients and 2 patients, 
respectively. The classification algorithm was run for each of the 9 training and testing 
sets. In each run, multinomial logistic regression was carried out on the training set to 
obtain fit coefficients using tissue type information determined by histopathology. Those 
fit coefficients were used as inputs for GEE. Optical diagnosis probabilities were 
calculated by using fit coefficients and scattering parameters from the testing set.  
A threshold was then applied to these probabilities to determine sensitivity and specificity 
for all different classifications including malignant vs. benign (normal and pancreatitis), 
which is considered a current clinical need, disease (adenocarcinoma and pancreatitis) vs. 
normal, adenocarcinoma vs. normal, adenocarcinoma vs. pancreatitis and pancreatitis vs. 
normal.  Confidence intervals for sensitivity and specificity were calculated using Wilson 
score interval with continuity correction [87]. Receiver operator characteristics (ROC) 
analysis curves also evaluated the classification ability of scattering parameters along 
with the area under curve (AUC) values. 
3.3 Results  
3.3.1 PCA Analysis and Classification Results  
The first three reflectance and fluorescence principal components, their scores, and their 
statistical significance for distinguishing between the tissue types are displayed in Fig. 
3.3. The first reflectance principal component score (RPC1) and the first fluorescence 
principal component score (FPC1) were the most statistically significant (p < 0.01) for 
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distinguishing adenocarcinoma from normal pancreatic tissue, distinguishing 
adenocarcinoma from chronic pancreatitis, and distinguishing chronic pancreatitis from 
normal pancreas.  
 
Figure 3.3 (A, B) First three principal components (accounting for 95% of the spectral 
variation) of the reflectance (A) and fluorescence (B) data sets. (C, D) Parameters 
extracted from principal component analysis (PCA) of tissue optical spectra, shown with 
their statistical significance for tissue classification. (C) The first reflectance principal 
component score was statistically significant for distinguishing adenocarcinoma from 
normal pancreatic tissue (p < 1x10
-4
), distinguishing adenocarcinoma from chronic 
pancreatitis (p < 9x10
-3
), and distinguishing chronic pancreatitis from normal pancreatic 
tissue (p < 2x10
-3
). (D) The first fluorescence principal component score was also 
statistically significant for distinguishing adenocarcinoma from normal pancreatic tissue 
(p < 1x10
-4
), distinguishing adenocarcinoma from chronic pancreatitis (p < 3x10
-3
), and 
distinguishing chronic pancreatitis from normal pancreatic tissue (p < 5x10
-3
). To remove 
negative values for ease of display, an offset of 4 was added to all principal component 
scores before they were plotted on the bar graph. 
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Variables from the PCA model were input into the tissue classification algorithm to 
distinguish between adenocarcinoma, chronic pancreatitis, and normal pancreas. The 
outputs of the classification algorithm were the optical diagnosis probabilities P(N), 
P(CP), and P(A) of each tissue site being normal, chronic pancreatitis, or 
adenocarcinoma, respectively. Ternary plots of the optical diagnosis probabilities P(N), 
P(CP), and P(A) were created for classification procedures that used both reflectance and 
fluorescence (Fig. 3.4), as well as reflectance only and fluorescence only (Fig. 3.5).  
 
Figure 3.4 Ternary plot of optical diagnosis probabilities (probability P(N) that a tissue 
site is normal; probability P(CP) that the site is chronic pancreatitis; probability P(A) that 
the site is adenocarcinoma), as determined by principal component analysis. The tissue 
sites are color-coded according to histopathological diagnosis. Shown alongside the 
ternary plot are the sensitivity, specificity, positive predictive value (PPV), and negative 
predictive value (NPV) for distinguishing malignant (adenocarcinoma) tissue sites from 
non-malignant (normal and chronic pancreatitis) tissue sites. Parameters from reflectance 
(first three principal component scores) and fluorescence (first principal component 
score) were both used in this method, and one threshold (P(A) > 0.3; red line) was 
employed to achieve the shown classification accuracy. 
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The resulting sensitivity, specificity, PPV, and NPV for distinguishing adenocarcinoma 
from non-cancerous tissues (Table 3.1) were calculated using cross-validation to be 91%, 
82%, 69%, and 95%, respectively.  The corresponding area under the ROC curve was 
0.89 for the algorithm including both reflectance and fluorescence PCA parameters. 
These results show the high diagnostic accuracy of the optical method employing both 
reflectance and fluorescence, as described in this report. Additional variations of the 
classification algorithm were run to compare the results obtained by using only 
reflectance variables (RPC1, RPC2, RPC3) and only fluorescence variables (FPC1, 
FPC2) with those obtained by using a combination of reflectance and fluorescence 
variables (RPC1, RPC2, RPC3, FPC1). For these comparisons, thresholds were manually 
selected such that the resulting sensitivity was the same (91%) for all three algorithms, 
and then the corresponding specificity, PPV, and NPV of the three algorithms were 
compared.  
 
Figure 3.5 Ternary plots of optical diagnosis probabilities (probability P(N) that a site is 
normal; probability P(CP) that the site is chronic pancreatitis; probability P(A) that the 
site is adenocarcinoma), as determined by optical spectroscopy with principal component 
analysis, using reflectance data only (A) and fluorescence data only (B). The tissue sites 
are color-coded according to histopathological diagnosis 
 
 42 
 
Using only reflectance variables, and choosing the threshold of P(A) > 0.20 for cancer 
diagnosis, the sensitivity, specificity, PPV, and NPV for distinguishing adenocarcinoma 
from non-cancerous tissues were 91%, 84%, 71%, and 95% (Table 3.1). The area under 
the ROC curve was 0.89 when only reflectance variables were employed (Fig. 3.6). 
Using only fluorescence variables, and choosing the threshold of P(A) > 0.22 for cancer 
diagnosis, the sensitivity, specificity, PPV, and NPV for distinguishing adenocarcinoma 
from non-cancerous tissues were 91%, 78%, 65%, and 95% (Table 3.1). The area under 
the ROC curve was 0.86 when only fluorescence variables were employed (Fig. 3.6).  
 
Figure 3.6 Receiver operating characteristic (ROC) curves for distinguishing malignant 
(adenocarcinoma) tissue sites from non-malignant (normal and chronic pancreatitis) 
tissue sites using PCA parameters from both reflectance and fluorescence data (solid blue 
line), PCA parameters from only reflectance data (dashed red line), and PCA parameters 
from only fluorescence data (dashed green line). The ROC curves were generated by 
applying a threshold to the optical diagnosis probability of adenocarcinoma. The area 
under the ROC curve was 0.89 for combined reflectance and fluorescence parameters, 
0.89 for only reflectance parameters, and 0.86 for only fluorescence parameters. 
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These results show that optical spectroscopy accurately classify pancreatic disease from 
normal tissues. Interestingly, for distinguishing between the tissue types measured in this 
study, using reflectance alone performed as well as diagnostic accuracy of the reflectance 
and fluorescence parameters (Table 3.1). This is a significant finding, as an optical device 
that used only reflectance would be less expensive, more compact, and faster when 
performing measurements. 
 
Table 3.1 Sensitivity, specificity, positive predictive value, negative predictive value, and 
area under the receiver operating characteristic curve of optical spectroscopy for 
distinguishing between pancreatic adenocarcinoma (A), chronic pancreatitis (CP), and 
normal pancreatic tissue (N). 
 
 
 
 
Method Classification Sensitivity Specificity
Positive 
Predictive 
Value
Negative 
Predictive
Value
Area 
Under 
Curve
Reflectance 
&Fluorescence 
A vs. (CP and N) 91% 82% 69% 95% 0.89
(A and CP) vs. N 83% 87% 92% 76% 0.90
A vs. N 97% 90% 89% 97% 0.96
A vs. CP 91% 71% 74% 89% 0.81
CP vs. N 77% 82% 79% 80% 0.84
Reflectance A vs. (CP and N) 91% 84% 71% 95% 0.89
(A and CP) vs. N 82% 87% 92% 74% 0.89
A vs. N 94% 95% 94% 95% 0.97
A vs. CP 91% 68% 73% 89% 0.81
CP vs. N 71% 87% 83% 77% 0.83
Fluorescence A vs. (CP and N) 91% 78% 65% 95% 0.86
(A and CP) vs. N 76% 87% 91% 68% 0.81
A vs. N 94% 90% 88% 94% 0.91
A vs. CP 81% 77% 77% 81% 0.78
CP vs. N 68% 85% 79% 75% 0.73
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3.3.2 Scattering Analysis and Classification Results  
Figure 3.7 (A) shows representative reflectance spectra from 630 to 760 nm, measured on 
three sites of each tissue type. Each of 9 spectra comes from all different patients.  At a 
glance, it is observed that the reflectance from adenocarcinoma sites is lower than those 
from normal and pancreatitis sites. Goodness of fit in Fig. 3.7 (A) suggests the employed 
rapid and simple scattering model well describes wavelength-resolved reflectance above 
630 nm. Given a linear relationship between the reflectance and the reduced scattering 
coefficients, mean wavelength- resolved reduced scattering coefficient for normal sites is 
higher than pancreatitis and adenocarcinoma (Fig. 3.7 (B)). Range (4 ~ 20 cm
-1
) of the 
extracted reduced scattering coefficient is consistent with typical human tissues [76]. 
Reduced scattering coefficients at several discrete wavelengths for each tissue type were 
listed in Table 3.2.   
 
Table 3.2 Scattering Power and Reduced Scattering Coefficients (mean ± SE)  
 SP µ’s(630 nm) 
cm
-1
 
µ’s(700 nm) 
cm
-1
 
µ’s(750 nm) 
cm
-1
 
Normal (39 sites) 0.21 ± 0.01 15.96 ± 0.36 15.61 ± 0.35 15.38 ± 0.35 
Chronic Pancreatitis 
(34 sites) 0.51 ± 0.06 12.66 ± 0.42 12.02 ± 0.43 11.63 ± 0.43 
Adenocarcinoma 
(32 sites) 0.77 ± 0.06 10.53 ± 0.43 9.70 ± 0.40 9.19 ± 0.38 
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Figure 3.7 Representative measured reflectance spectra (gray-dashed lines) and their fits 
(colored-solid lines) from different types of pancreatic tissues including normal (blue), 
chronic pancreatitis (green) and adenocarcinoma (red). Reflectance intensity and slop 
show a distinct difference between three pancreatic tissue types (B) Mean of estimated 
wavelength-dependent reduced scattering coefficients for three pancreatic tissue types 
(39 sites for normal, 34 sites for chronic pancreatitis and 32 sites for adenocarcinoma). 
(C) Extracted reduced scattering coefficients at 630 nm for three pancreatic tissue types. 
The reduced scattering coefficients at 630 nm are significantly different for all 
comparisons (N vs. CP, N vs. A, and CP vs. A) with p < 0.001. (D) Extracted scattering 
power from three tissue types. The scattering powers are also significantly different for 
all comparison with p < 0.001.  Error bars in (B),(C) and (D) represent the standard error. 
 
Figure 3.7 (C) and (D) display bar plots of the estimated µ’s(630 nm) and scattering 
power γ of three tissue types. Compared to normal and pancreatitis sites, µ’s(630 nm) of 
adenocarcinoma is significantly lower (p < 0.001). In contrast, scattering power of 
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adenocarcinoma is significantly higher than normal and pancreatitis tissues (P < 0.001). It 
is noted that scattering powers of almost all normal sites converges to 0.2, which is the 
experimental minimum value [81].  According to Mie theory [79, 88], large scatterer (> 1 
µm) such as nuclei are likely to be the major scattering source in normal pancreatic 
tissues.    
Using tissue classification algorithm, two scattering parameters, µ’s(630) and scattering 
power γ  distinguish adenocarcinoma from benign tissues with the sensitivity of 94% and 
specificity of 75%. The result suggests that pancreatic tissue scattering property is 
diagnostically useful for separating adenocarcinoma in the setting of pancreatitis. 
Sensitivity and specificity for other classifications are listed in Table 3.3.  ROC analysis 
also demonstrates the diagnostic ability of tissue scattering parameters in discriminating 
each pancreatic tissue type, as shown in Figure 3.8. The area under the curve (AUC) is 
0.89 and 0.97 for distinguishing malignancy from benign and adenocarcinoma from 
normal, respectively.   
 
Table 3.3 Sensitivity and Specificity for different classification (Confidence Interval with 
α = 0.05) 
 Sensitivity  Specificity 
Malignant (A) vs. Benign (CP & N) 94 (78 – 99) % 75 (64 – 84) % 
All Pathology (A & CP) vs. N 88 (77 – 94) % 90 (75 – 97) % 
A vs. N  94  (78 – 99) % 95 (81 – 99) % 
A vs. CP  81 (63 – 92) % 71 (52 – 84) % 
CP vs. N 88 (72 – 96) % 80 (63 – 90) % 
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Figure 3.8 The receiver operating curves (ROCs) for different classifications with the 
area under curve (AUC). 
 
3.4 Discussion 
In this pilot study, the clinically-compatible reflectance spectroscopy and the rapid 
scattering model were employed to investigate the diagnostic potential of pancreatic 
tissue scattering properties in freshly excised pancreas.   
Reflectance Only Dataset In this study, tissue classification employing only reflectance 
provided nearly identical results to those obtained with a combination of reflectance and 
fluorescence. This finding can possibly be attributed to an overlap between the 
information encoded in the reflectance and fluorescence principal components. The 
reflectance data is known to contain notable information about tissue scattering, which is 
partially due to collagen in the tissue. However, collagen is also a prominent endogenous 
fluorophore in human pancreatic tissue, so the information about collagen is also found in 
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the fluorescence spectra. Therefore, it is to be expected that the reflectance and 
fluorescence principal components would include overlapping information.  
In Figure 3.3 (B), the first fluorescence principal component contains a spectral feature 
near the peak emission wavelength (~400 nm) of collagen fluorescence, which was 
previously shown to distinguish between these tissue types in our previous work [68] . 
Fig. 3.3 (A) shows that the second and third reflectance principal components display 
spectral features similar to those of hemoglobin absorption, which has a distinctive Soret 
peak near 420 nm and secondary peaks near 545 nm and 575 nm. Since absorption (from 
hemoglobin) and scattering (from tissue components including collagen) play prominent 
roles in determining the measured reflectance spectrum, we can reasonably attribute that 
the first reflectance principal component to primarily collagen scattering and the second 
and third reflectance principal components could to hemoglobin absorption. Since the 
fluorescence spectrum also contains prominent information about collagen, as well as 
artifacts of hemoglobin absorption, it is quite possible that the fluorescence data is not 
providing a significant amount of diagnostic information that is different from that 
provided by the reflectance. 
Discussion on scattering In our study, the wavelength-resolved reduced scattering 
coefficient and scattering power of human pancreatic tissue have been estimated based on 
calibration using a set of synthetic tissue-simulating phantoms. Although tissue scattering 
signal reveals tissue morphology or micro-architecture, detailed mechanism on how 
intracellular components (such as nuclei, mitochondria and membrane) and extracellular 
matrix (collagen) contribute to the entire scattering is very complex and is not well 
understood.  In previous work [78, 79] attempting to explain power law dependence with 
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Mie theory, it was found that the scattering power is related to average scatterer size. Our 
study shows that the scattering power for adenocarcinoma and chronic pancreatitis is 
larger than that of normal tissues, suggesting an increased contribution of small-size 
scatterer. According to Mie theory, scattering power does not significantly change below 
0.37 if scatterer size is larger than a certain size (~1  µm), implying that relatively large 
intracellular components such as nuclei (a typical size of normal nuclei is known to be 
around 9 µm) and mitochondria could be major scatterers in normal pancreatic tissues. 
Since collagen content is reported to increase in adenocarcinoma and pancreatitis due to 
stromal fibrosis, the increase of scattering power is possibly attributed to an increase of 
collagen content. In contrast, the scattering amplitude of adenocarcinoma decreases from 
normal to pancreatitis, which is an opposite trend to some of the other tissue types.   
Study Limitations A key limitation of this work is a small number of patients due to 
difficulties in frequent attendance to a suitable surgical case. Thus, our study needs to be 
considered a pilot study that assesses potential of reflectance spectroscopy for real-time 
pancreatic cancer detection.  One potential problem that occurs in a statistical analysis 
evaluating multiple sites measured from a single patient (i.e. intra-patient correlation) is 
addressed by employing GEE method in tissue classification algorithm. GEE has been 
previously developed to account for the intra-patient correlation in medical physics 
studies, including ophthalmologic studies that investigate two eyes in a single patient 
[89].  
Another limitation is that the study is restricted to ex vivo measurements from freshly-
excised surgical specimen. Given the study focuses only on tissue scattering properties, it 
is unlikely that scattering properties significantly change within 30 minutes after 
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excision. The analyzed wavelength range (630 to 760nm) is also independent from blood 
absorption that could significantly alter either by a drain of internal blood after excision 
or remaining hemorrhage even after clean up when site is cut for optical interrogation. A 
preliminary study demonstrating technical feasibility of in vivo optical measurement on 
pancreas showed that ex vivo and in vivo reflectance spectrum acquired from the same 
site were almost identical with a minor discrepancy in the main blood absorption 
wavelength (420 and 550 nm).  The advantage of ex vivo study is to obtain the gold-
standard histopathology, which is impossible via a current standard diagnostic procedure 
for pancreatic cancer, unlike other type of cancers where core biopsy is available on 
intact tissues. The gold-standard histology is essential to establish an accurate tissue 
classification algorithm and is expected to play an important role to expand this technique 
to a future in vivo studies employing endoscopic-compatible fiber optic probe.    
3.5 Conclusion  
This pilot study revealed that pancreatic tissue scattering properties estimated by 
reflectance spectroscopy coupled with a simple scattering model, had a diagnostic power 
to distinguish malignant tissues from non-malignant tissues. Reflectance spectroscopy is 
suitable for clinical translations because of its rapid acquisition and processing time, and 
compactness and cost-effectiveness of the device.  
 51 
 
Chapter 4.                                                                                                                       
Ray-traced Monte Carlo Simulation for Fluorescence Measurements in Turbid 
Media 
4.1 Introduction 
Fluorescence spectroscopy and imaging have become invaluable tools in biology and 
biomedicine fields due to their ability to differentiate cells and sub-cellular components which 
emit fluorescence with a high specificity from a background with no fluorescence [90]. In both 
fluorescence spectroscopy and imaging system, sample scattering is always a technical issue to 
address for an accurate analysis of the sample fluorescence. For spectroscopy, intrinsic 
fluorescence signal or spectrum needs to be recovered from the measured fluorescence that 
detects the re-emitted fluorescence undergoing absorption and scattering in turbid media. In the 
imaging system, scattering is the main source of a signal distortion and determination of 
penetration depth.     
As a quantitative method, Monte Carlo (MC) simulation has been employed to evaluate the 
performance and design the optics in the optical spectroscopic or imaging systems probing turbid 
biological tissues. Reflectance confocal imaging techniques in turbid media have been assessed 
using an embedded Monte Carlo function in the commercialized ray-tracing software (ASAP) 
[91, 92]. Fluorescence collection efficiency in multiphoton microscopy has also been investigated 
[93], but only fluorescence emission has been modeled. Probably, due to the incomplete 
implementation and limitations of Monte Carlo function in the software for fluorescence 
occurrence and propagations, there have not been any previous studies that report the full 
fluorescence path modeling in turbid media with fluorescence imaging system.          
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For fluorescence spectroscopic system, Monte Carlo (MC) simulation code [16, 94] has been 
developed to accurately model fluorescence photon propagation in biological tissues. The code 
has been extensively employed to design the depth-sensitive fiber-optic probes using different    
source-detection separations [95], angled fiber [96], ball lens [97], or combined beveled fiber with 
a ball lens [98]. However, MC simulation code has a limitation in incorporating complex 
mathematical equations for ray-tracing through the specialized lenses such as graded-index 
(GRIN) lens and aspherical lens, or compound lenses and series of different lenses.    
Thus, the idea of combining ray-tracing software and MC codes could be an effective and useful 
way to address technical needs in simulation methods for both spectroscopic and imaging 
applications. In this paper, we introduce a ray-traced MC (RTMC) simulation method to combine 
ZEMAX®  ray tracing software and MC simulation code to model a complete path of 
fluorescence excitation, propagation and detection on turbid media by optical spectroscopy or 
imaging system. We verified the RTMC simulations both computationally and experimentally. 
4.2 Basic Concept of RTMC Simulation 
 The RTMC simulation works in a complementary way such that ZEMAX®  traces rays through 
the optical system including a source, lenses, and detector, and MC simulation models photon 
propagation inside the turbid media. (Fig. 4.1) In detail, the non-sequential mode of ZEMAX®  
launches a maximum of 10
6 
rays from a virtual source for the excitation path tracing. The 
launched rays pass through the optical components and contact a virtual detector that locates at 
the surface of targeted samples. When each ray meets the detector, ZEMAX®  ray tracing mode 
exports the array file that contains the geometrical information of the incident rays, including 
incident positions (x,y and z coordinates), angle (cos α, cos β and cos γ) and intensity.  
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Figure 4.1 Basic concept of the RTMC simulation. ZEMAX®  performs ray tracing 
through optical components from source to media, and from media to detector. Once the 
ray enters the media, Monte Carlo code simulates fluorescence occurrence and 
propagation. While the embedded Monte Carlo function in ZEMAX®  is able to model 
diffuse reflectance including scattering and absorption, it has limitations to simulate 
fluorescence propagation. In the MC code, complex ray tracing equations have to be built 
manually, which restricts employing a variety of optical components. RTMC method 
combines these two methods in a complimentary way to enable complete fluorescence 
ray tracking through optics and turbid samples. 
   
Exported array file from ZEMAX®  is imported as the initial photon distribution for MC 
simulation that is modified from the original code [99]. During simulating fluorescence 
occurrence and propagation inside turbid media, the geometrical and spectral information of the 
photons exiting the surface is saved in compatible file format with ZEMAX®  source object. 
Second ZEMAX®  ray tracing mode employs this array file as a source object to trace the emitted 
fluorescence signal from the sample surface to the detector via optical components. Detector in 
ZEMAX®  can display both 2-D graphical distribution of detected ray and the spectroscopic data.  
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4.3 Computational Verification 
To prove the accuracy of interfacing ZEMAX®  and MC code via the ray data array file, RTMC 
simulation was computationally verified with reflectance and fluorescence measurements 
simulations. The simulations were performed on optical tissue models using two flat-ended 
optical fibers for light delivery. Simulated reflectance and fluorescence with RTMC simulations 
were compared with those simulated by the previously developed MC code in MATLAB[100]. 
Epithelial colon tissue models were employed as two-layered optical model, which consists of a 
mucosa layer with finite thickness atop a semi-infinite submucosal layer (Table 4.1) Optical 
transport properties (scattering coefficient, absorption coefficient and anisotropy) at fluorescence 
excitation and emission wavelength, and fluorophore properties (absorption coefficient and 
quantum yield) were employed from the previous study [101]. Three different types of models 
depending on disease status were employed. Tissue 1 was normal colon, tissue 2 was 
adenomatous tissue having different optical transport properties in mucosal layer, and tissue 3 
was also adenomatous model with the same optical properties with tissue 2,  but with thicker 
submucosal layer [101]. 
Table 4.1 Optical Properties of the Three Epithelial Tissue Models  
Wavelength, 
λ (nm) 
Layer 1 (n1 = 1.35 g1 = 0.9) Layer 2 (n2 = 1.38 g2 = 0.95) 
µa (cm
-1
) µs (cm
-1
) µaf (cm
-1
) z (µm) µa (cm
-1
) µs (cm
-1
) µaf (cm
-1
) 
Tissue 1 
(Normal) 
355 (Excitation) 12 200 
0.5 500 
12 200 
1.5 
550 (Emission) 3 90 3 9 
Tissue 2 
(Adenoma) 
355 (Excitation) 20 120 
0.5 500 
12 200 
1.0 
550 (Emission) 10 70 3 90 
Tissue 3 
(Adenoma) 
355 (Excitation) 20 120 
0.5 700 
12 200 
1.0 
550 (Emission) 10 70 3 90 
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Figure 4.2 Comparison of MC and RTMC simulation results for reflectance and 
fluorescence measurements using fiber-optic probe on epithelial tissue model 1 (a), 
model 2 (b) and model 3 (c) at different source-detector separations. 
 
Excitation light from a source was delivered to the tissue samples via an optical fiber 
with the core diameter of 600 µm and 0.22 NA. The identical fiber delivered the   emitted 
reflectance and fluorescence from the sample. Source-detection separations (ρ) were 0, 
300, 600, 900, 1200, 1500 and 1800 µm. In the RTMC simulation, optical fibers were 
created using two concentric cylinder volume objects with inner and outer radius of 300 
and 310 µm respectively from the ZEMAX®  library. Refractive indices of inner and 
outer cylinders were set as 1.450 and 1.433 respectively to create a total internal 
reflection with 0.22 NA. A total of 1×10
6
 photons were launched from the source for 
each simulation method. 
Figure 4.2 shows the comparison of MC and RTMC simulation on three different tissue 
computational models. Average percent errors between two methods for all the source 
and detection separations and tissue types are 3.5% and 7.1% for reflectance and 
fluorescence, respectively. It is noted that accuracy was consistent over a wide range of 
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detected photon intensities with an order of 10
4
, indicating the interface between 
ZEMAX®  and MC code using a geometrical photon array file works as expected. 
4.4 Experimental Verification  
Experimental verification of the RT-MC simulation was performed on depth-sensitive 
fluorescence measurement of two-layered optical phantoms as shown in Fig. 4.3. The 
depth-sensitive optical setup was designed by employing an aspherical lens with high NA 
as an objective lens, which has not been employed in any previous MC simulation 
studies, to the best of our knowledge.   
4.4.1 Depth-Sensitive Fluorescence Spectroscopy 
The depth-sensitive fluorescence measurement system utilized a 355 nm pulsed laser 
(PNV001525-140, JDS Uniphase, San Jose, CA) for excitation (Fig. 4.3). Laser light 
emitted from the multi-mode fiber (core diameter = 100 µm) was collimated by a plano-
convex lens (LA4936-UV, Thorlabs, Newton, NJ). This collimated beam was reflected 
by a dichroic mirror (FF365-Di01, Semrock, Rochester, NY) and then focused by an 
aspherical lens (49-587, Edmund Optics, Barrington, NJ) with NA = 0.5 and working 
distance of 15 mm.  Emitted fluorescence signal from the phantoms was collected by the 
same aspherical lens, passed through the dichroic mirror and a long pass filter (LP02-
355RS, Semrock), and then focused into a detection multi-mode detection fiber with 0.22 
of NA and 600 µm of core diameter by another plano-convex lens (LA1131-A, 
Thorlabs). The collected fluorescence signal was transmitted to a spectrograph (MS 125, 
Oriel Instruments, Stratford, CT) coupled ICCD (ICCD 2063, Andor Technology, 
Belfast, UK) for spectra acquisition with 1 nm resolution. All the employed lenses and 
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fibers were modeled in the ZEMAX®  non-sequential mode with the downloaded 
components provided from the manufacturer’s website.  
 
Figure 4.3 Schematic of experimental depth-sensitive fluorescence spectroscopy system 
setup for tissue-simulating phantom verification 
 
4.4.2 Two-layered Fluorescence Phantom Fabrication and Characterization 
Two-layered fluorescence phantoms were constructed with a solid agarose-based top 
layer and a solid polydimethylsiloxane (PDMS)-based bottom layer. Hydrophobic 
property of PDMS prevented diffusion of fluorophore from the hydrophilic top layer, 
eliminating a need of any sheet between two layers, which could have unknown optical 
effects.  Thicknesses of top and bottom layers were 1 mm and 10 mm, respectively. The 
lateral size of both layers was 60 mm in diameter to ensure a semi-infinite medium. 
Standard fluorophores, Rhodamine 6G (R4127, Sigma Aldrich, St. Louis, MO) and 
POPOP (P3754, Sigma Aldrich) were added to the top and bottom layers respectively for 
spectral separation in measured spectra. An agarose powder (161-3101, Bio-Rad 
Laboratories, Hercules, CA) was mixed in boiled DI (de-ionized) water with 2% 
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concentration, and thoroughly dissolved to obtain a homogeneous solution. When the 
mixture was cooled to 60~70 ˚C, pre-calculated volume of Intralipid (I141, Sigma 
Aldrich) was added to mimic the scattering coefficients of biological tissues. 1mM of 
Rhodamine 6G solution in DI water was added to the mixture to be diluted to 0.5 µM. 
When the temperature of the mixture reached 40 ˚C, a pre-calculated volume of the 
mixture was transferred into a petri dish to create a top layer of specified thicknesses (1 
mm) and then cured for 1 hour in a cool, dark enclosure. 
The PDMS-based bottom layer was fabricated according to a previously described recipe 
[102]. Briefly, a specific weight of titanium oxide (TiO2) powder (Ti-602, Atlantic 
Equipment Engineers, Upper Saddle River, NJ) was added as scatterers in PDMS curing 
agent to mimic biological tissue scattering. To dissolve TiO2 completely, the mixture was 
placed in an ultrasonic bath for 20 minute and stirred manually every 5 minutes. Then, 
the mixture and PDMS (Sylgard 184, Dow Corning, Midland, MI) were mixed with 1:10 
ratio. A pre-calculated volume of 1 mM POPOP solution in cyclohaxane was added to 
this mixture to create 10 µM concentrations. The mixture was   transferred to a petri dish, 
placed in a vacuum chamber for the de-gassing process for 30 minutes, and cured for 24 
hours at room temperature. 
The absorption coefficients (µa) and scattering coefficients (µ s) of all fabricated layers 
were determined by the integrating sphere (RT-060-SF, Labsphere, North Sutton, NH) 
measurements and estimation using an inverse adding-doubling (IAD) algorithm. 
Detailed setup and procedure has been described previously [82]. The fluorescence 
absorption coefficients were calculated from the transmission measurement of the 
spectrophotometer (DU800, Beckman Coulter, Fullerton, CA) using a 1cm path-length 
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cuvette. Input parameters for optical properties of the manufactured phantoms are shown 
in Table 4.2. Refractive indices were set to 1.33 and 1.4 for the top and bottom layers 
respectively, and anisotropy was set to 0.9 in both layers. Two different phantoms were 
additionally manufactured and measured to add variations in the experimental 
verification. In the second phantom, Intralipid concentration was three times higher than 
the first phantom with other properties being the same. The third phantom had only 
variation of a 0.5 mm-thick top layer compared to the first phantom.  
Table 4.2 Optical Properties and Thickness of the Top and Bottom layer for Two-layered 
Phantoms (µ s: scattering coefficient, µafx: fluorescence absorption coefficient, z = 
thickness) 
 
4.4.3 Depth-Sensitive Fluorescence Measurements  
For depth-sensitive fluorescence measurements, a focal point was scanned in z-direction 
from the surface to 1 mm deep, in step sizes of 250 μm, using a micro linear actuator 
(LTA-HS, Newport, Irvine, CA). Excitation laser intensity was set to make sure of no 
photo-bleaching. Acquisition time per one depth was around 2 seconds. Recorded 
fluorescence spectra were background subtracted and corrected with ICCD spectral 
response [75]. Figure 4.4 displays fluorescence emission spectra at different focal depth, 
showing a distinct separation of peak emission wavelength between POPOP (420 nm) 
and Rhodamine 6G (550 nm). As the focal point goes deeper, fluorescence emission 
Wave-
length 
(nm) 
Top Bottom 
µ s 
(cm
-1
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(cm
-1
) 
z 
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(cm
-1
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(cm
-1
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26 ± 3 
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intensity of Rhodamine 6G increases with a corresponding decrease in POPOP intensity.  
Top layer sensitivity was defined as Rhodamine 6G emission intensity (that is the 
integrated intensity from 520 to 630 nm) divided by the sum of Rhodamine 6G and 
POPOP emission intensity (from 360 to 480 nm).    
 
Figure 4.4 Fluorescence emission spectra variation of two-layered optical phantom at 
different focal depths. As the focal point goes deeper, a relative intensity of the top layer 
(Rhodamine 6G, 560 nm peak emission) decreases while the one of the bottom layer 
increases (POPOP, 420 nm peak emission)    
 
4.4.4 Comparison between simulation and the actual measurement   
Figure 4.5 shows the top layer sensitivity at each focal depth estimated from RTMC 
simulations and calculated from the actual measurements for three different phantoms. 
For all phantoms, top layer sensitivity reduces as the focal point goes deeper and closer to 
the bottom layer. Overall, the RTMC simulation predictions and the experimental 
measurements are well agreed in terms of a decreasing trend over the scanning depth 
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range and the absolute values of top layer sensitivity in all three different phantoms. 
Mean percent error for all depth points is less than 15%. In particular, RTMC simulation 
estimates the top layer sensitivity at the surface accurately.  
 
Figure 4.5 Experimental verification results on three manufactured two-layered 
phantoms (a) phantom 1 (b) phantom 2 and (c) phantom 3. Top layer sensitivity is 
compared between measurements and simulations by 0.25 mm step size of focal point 
until 1.00 mm. Solid lines with solid circles indicate actual measurements and empty 
rectangles indicates RTMC simulation results. In the measurements, error bars present 
the standard deviations 
 
The simulation and experiments well predicts an understandable variation of the top layer 
sensitivity in three phantoms as intended in phantom design. The top layer sensitivity of 
the second phantom is higher than the first phantom due to higher scattering coefficients 
of the top layer causing more fluorescence photons to scatter, which increases a chance of 
detection. The lower top layer sensitivity of the third phantom is attributed to a thin top 
layer with less amount of Rhodamine 6G fluorophore amount and more interference of 
POPOP fluorescence from the bottom layer.     
Difference between the simulations and experiments is observed at deeper focal points 
(between 0.75 and 1 mm) in all three phantoms. This could be attributed to either 
Focal Depth (mm)
0.00 0.25 0.50 0.75 1.00
0.0
0.2
0.4
0.6
0.8
1.0
Measurement
RTMC Simulation
Focal Depth (mm)
0.00 0.25 0.50 0.75 1.00
0.0
0.2
0.4
0.6
0.8
1.0
Measurement
RTMC Simulation
Focal Depth (mm)
0.00 0.25 0.50 0.75 1.00
T
o
p
 L
a
y
e
r 
S
e
n
s
it
iv
it
y
0.0
0.2
0.4
0.6
0.8
1.0
Measurement
RTMC Simulation
(a) (b) (c)
 62 
 
experimental or computational errors. The decreasing slope of the top layer sensitivity is 
relevant to the overall depth sensitivity of the device. The gradual slope in the 
experimental results compared to the one from the simulations would indicate the 
imperfection of optics alignment in the instrument set up. In the RTMC model, the fixed 
values of anisotropy, which is likely to be wavelength-dependent, also could cause some 
incomplete tracking of photon propagations.  
In spite of these small errors, the good agreement between the RTMC simulations and 
experiments verifies that RTMC simulation is a computational tool to provide an accurate 
estimation of fluorescence excitation and detection by optical spectroscopy system, as 
well as a transport inside by-layered turbid media model. 
4.5 Conclusion 
In this chapter, RTMC simulation method was proposed and developed with an aim to fill 
a technical gap of current computational tools by providing an accurate modeling of a 
complete path of fluorescence excitation, detection and propagation through optical 
system and turbid media. Applications of RTMC are not limited to employing a 
traditional optical component such as lens and filter. Due to flexibility and ongoing-
update of a huge ZEMAX library, the RTMC has a potential to computationally model an 
optical fluorescence sensing in turbid media by optoelectronic devices such as light-
emitting diode, laser diode and photodiode, which have not been employed in the 
previous simulation works.  
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Chapter 5.                                                                                                                    
Prototype Design of Optoelectronic Microprobe 
5.1 Introduction 
5.1.1 Motivation 
Optical diagnostics have made considerable advancements in recent years as a method to 
provide non-invasive, quantitative, and rapid sample/tissue analysis in a clinical setting. 
In cell biology alone, numerous advancements have been enabled through the 
development of fluorescence-based analysis methods. Furthermore, biomedical studies 
(including studies involving cancer and other diseases) have been transformed through 
commercial technology for whole body animal imaging (e.g., Caliper Life Sciences IVIS 
imaging system). In more clinical settings, optical FDA approved technologies are 
routinely employed (such as the pulse oximeter, Philips BiliChek bilirubinometer, the 
DentalEZ Identafi oral cancer screening system, and MELA Sciences MelaFind system 
for early melanoma detection).  
For many clinical applications, including those discussed above, optical technologies are 
not subject to a confined space because the studied tissue is readily accessible from 
outside the body (i.e., oral cavity or skin). Therefore, developed technologies are 
typically large footprint instruments, including robust and expansive 
spectroscopy/imaging systems that access human tissue via remote fiber-optic probes. 
Reports in recent literature describe numerous technologies developed with fiber-optic 
probes [97, 103-107], employed because they are easy-to-use, reliable, and enable remote 
sample sensing (i.e., away from equipment). Critical limitations to such approaches 
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include the relative rigidity of fiber-optic probes (inability to undergo tight bends) and 
inability of fiber-optic probes to enable volumetric mapping within a confined space. 
Here, we consider the clinical application of needle-based clinical methodologies, 
including for tissue diagnostics and drug/treatment delivery. Needle-based methodologies 
have numerous applications, including fine-needle aspiration for cancer detection 
(employed for breast [104, 108], lung [36, 109, 110], prostate [111, 112], and pancreatic 
cancers [22, 55-57] diagnosis) as well as for nerve block treatments (researched by 
Philips) [113-115]. There are two common approaches for needle-based analysis of 
tissues: imaging and spectroscopy. Imaging through a hollow needle has been 
demonstrated with the development of the needle-based confocal imaging system 
Cellvizio [50, 116, 117], commercialized by Mauna Kea. Limitations to imaging based 
systems include their small field-of-view and complicated/time expensive requirement 
for real-time quantitative image analysis. Such applications employing fiber-optic probes 
are limited by their rigidity, lack of volumetric mapping, and/or constrained center-to-
center spacing between source and detectors. 
We proposed to develop an optoelectronic microprobe, constrained within a hollow 
needle (including common 19, 22, and 25 gauge needles), for quantitative volumetric 
optical mapping within tissues. Primary advantages, compared to fiber-optic based 
technologies, include the robustness of miniature microelectromechanical systems 
(precisely manufactured to dimensions < 1 mm) and their compactness (provide ability to 
withstand tight bending radii). Furthermore, optical modules were designed to preserve 
center-to-center spacing (utilizing long axis of the needle) of optical sources and 
detectors typical of fiber-optic probe-based measurements [55], critical for accurate tissue 
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diagnostics by increasing the tissue volume studied. Additionally, the optoelectronic 
microprobes can be manufactured with numerous probe geometries to enable volumetric 
mapping that is impossible with current fiber-based approaches. 
5.1.2 Scientific Background 
EUS-compatible optoelectronic sensing technology provides additional diagnostic 
information to supplement cytology based diagnosis and overcome its limitations, either 
by providing independent diagnosis of the pancreatic abnormality or by guiding the 
endoscopist performing EUS to select the most likely areas to obtain diagnostically 
relevant cytological material.  
Preliminary studies in the human pancreas including works in the chapter 3, have shown 
that optical sensing can provide a new source of contrast for the detection of pancreatic 
cancer (Fig. 5.1) [22, 55-57]. The interaction of light with tissue can be measured and 
analyzed to obtain diagnostic information in vivo [7, 66, 90, 94, 101]. In the pancreas, 
histopathological analysis shows enlarged cell nuclei and abundant collagen in 
adenocarcinoma, which can be accurately detected by tissue optical sensing, thereby 
providing an opportunity to improve pancreatic neoplasia diagnosis [22, 55-57].  
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Figure 5.1 Results are presented from a clinical pilot study from freshly-excised 
pancreatic tissues from 18 patients. (A) Averaged reflectance spectra revealed significant 
differences between normal, chronic pancreatitis, and pancreatic adenocarcinoma. 
(Normalized spectra of Figure 3.1 in the chapter 3). Dotted vertical lines identify two 
wavelength bands (centered at 470 and 630 nm) proposed for the optoelectronic 
microprobe. (B) The ratio of summed intensities within each wavelength band accurately 
distinguished among the three most prevalent pancreatic tissues. All error bars represent 
standard error.  
 
5.1.3 Basic Concept 
Based on the strong preliminary results, we believe optical diagnostics will enhance the 
technical capability of the endoscopist to provide a more accurate diagnosis and 
dramatically alter clinical practice by improved triage of patients to appropriate therapy 
(surgery or not). In addition to the enhanced accuracy of diagnosis, the technology 
outlined here (see microprobe technology compatible with commercially-available FNA 
needles in Figure 5. 2) will provide volumetrically mapped tissue assessment by rapidly 
measuring multiple tissue sites, unlike EUS-FNA, which requires multiple needle passes 
into tissue for a single aspirate collection. Thus, the proposed approach has the potential 
to address the important unmet need of pancreatic neoplasia diagnosis (low negative 
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predictive value of cytology) by improving the diagnostic capability of EUS, thereby 
leading to improved triage of patients to appropriate therapy. 
 
Figure 5.2 The optoelectronic microprobe is compatible with commercially-available 
EUS-FNA technology. Specifically, we have designed our microprobe to be compatible 
with FNA needles similar to the Cook Medical EchoTip® ProCore™ needles. (top) The 
EUS-FNA needle is compatible with current standard-of-care endoscopes employed for 
pancreatic procedures. The ProCore™ needle has a ~4mm window opening that will 
allow optical interrogation of tissue. (bottom) The microprobe electronics will be exposed 
when the protection sheath is removed to expose the needle tip. Once the sheath exposes 
~2 cm of needle, the microprobe will be ready for optical measurements 
 
5.1.4 Innovation 
Using optical contrast for clinical tissue diagnostics is not a new idea [66, 90]. However, 
due to the challenges associated with accessing this internal organ, relatively little 
research in biomedical optics has been conducted in the human pancreas. Field effect 
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analysis [53, 118] of duodenal tissues adjacent to the pancreas and limited optical 
coherence tomography [119, 120] studies in the pancreas do not address the targeted 
clinical problem discussed here. Recent studies have established only feasibility for 
needle-based confocal laser endomicroscopy [116, 121, 122], as diagnostic utility has 
proven elusive even in large clinical studies [50, 121, 123]. 
In this chapter, we report optical-fiber-based technology to obtain the first optical 
spectroscopy data during pancreatic EUS-FNA procedures, based on the success of 
optical spectroscopy on freshly excised human pancreatic tissues [55] and corresponding 
pancreatic tissue classification algorithms using such optical data as inputs [22, 56, 57]. 
Our ex vivo data set has grown considerably and enabled the first robust analysis of the 
potential of optical spectroscopy to differentiate between malignant and non-malignant 
pancreatic tissues (Fig. 5.1).  
Technically, the novel design of microfabricated optoelectronic components proposed 
here promises to revolutionize minimally-invasive tissue optical spectroscopy. To the 
best of our knowledge, this is the first-ever development of an integrated optoelectronic 
system for EUS-FNA compatible tissue diagnosis. Compared to the optical-fiber-based 
system we developed previously [10, 55], the proposed technology dramatically reduces 
cost (~ 20x) and instrumentation footprint (~100x) with comparable (and sometimes 
superior) optical performance including source power and detector sensitivity[12], and 
durability. Further, the proposed concept (Fig. 5.3) enables rapid volumetric mapping of 
pancreatic tissues to interrogate larger tissue volumes than those aspirated by EUS-FNA. 
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Figure 5.3 The optoelectronic microprobe is inserted through the hollow needle 
employed for EUS-FNA and rapidly interrogates tissue with pulses of light, providing 
real-time guidance for FNA (thereby improving sensitivity) or classifying tissue for 
diagnosis (proving the absence or presence of malignant disease). Shown are two source-
detector sub-units to illustrate the technology’s volumetric mapping capabilities with 
linear translation. Future designs could incorporate multiple repeated sub-units for tissue 
assessment over an extended tissue volume. 
 
5.1.5 Design Concept and Requirement  
To estimate a reflectance ratio at multiple points, the microprobe has two source-detector 
sub-units that consist of two LEDs (470 nm and 630nm) and one phototransistor (Fig. 
5.4). The source-detector modules are arranged on a fabricated printed circuit board with 
contact pads and patterned electrical interconnections for all probe wiring. Measurements 
will be collected from both sub-units simultaneously, enabling real-time volumetric 
optical mapping of pancreatic neoplasia. Within each sub-unit, the two LEDs will be 
fired sequentially to avoid detector cross-talk. 
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Figure 5.4 Illustration of proposed microprobe. The microprobe will be guided to the 
tissue site within a retractable protective sheath in the EUS hollow needle. Prior to 
measurement, the protective sheath will be retracted from the optical sensing window 
which is encapsulated with a transparent biocompatible epoxy to protect optoelectronics 
and electrical connections. The 5 mm long sensing window is created within a 19 Gauge 
EUS-FNA needle.   
 
Successful integration with EUS-FNA requires the fabricated optoelectronic sensor 
(including optical sources, detectors, wiring, and connections) to fit within a hollow 19 
Gauge [36, 50, 124] needle with a 0.85 mm inner diameter. For reflectance optical 
sensing, the diffused reflectance at multiple wavelengths must be measured with a high 
SNR. In particular, optical sensing must not be distorted by blood absorption, which has 
been demonstrated by our in vivo study on pancreatic surgery patients [125]. To correctly 
interrogate tissue sites, the probe must be moisture-proof. Heat dissipation from the 
optoelectronic components must be minimized to neither damage nor alter the optical 
properties of the target tissues. To minimize the error due to patient motion artifacts, the 
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optoelectronic probe must provide a real-time data analysis. Mechanically, the system 
must withstand endoscopic delivery. Critical design requirements and specification are 
described in Table 5.1. 
Table 5.1 Design Requirements and Specifications of the Proposed Optoelectronic 
Microprobe compatible with a 19G hollow needle 
 
5.1.6 Objective and Design Scope  
In this chapter, we describe the first prototype of optoelectronic microprobe. First, we 
fabricated a relatively large-scale printed circuit board with metal patterns to test 
assembly process and to characterize the performance of each optoelectronic component. 
The microfabricated board also has different designs on source-detection separations in 
the assumption of tissue optical sensing inside a 19G hollow needle in order to test the 
feasibility of reflectance and fluorescence sensing.  
 
 
 
 
Design Requirements Specifications 
Fit within 19G Needle Diameter  < 850 µm; Length  < 5 mm 
Multi-Spectral Sensing SNR > 25 for 460 nm and 650 nm 
Real-Time Analysis < 1 s 
Waterproof No performance degradation in water during 5 minutes 
Low Heat Generation Temperature increase < 1°C 
Mechanically  Durable No breakage or performance degradation during insertion 
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5.2 Methods  
5.2.1 Engineering Analysis - Optical Simulation  
Based on our preliminary surgical studies on human pancreatic tissues [55-57, 126], the 
die-level LED chips were selected for wavelengths of 460 nm (460DA3547, Cree, 
Durham, NC) and 650 nm (C4L 12T5, Chip4Light, Germany) because of their sufficient 
optical power with relatively low electrical power consumptions [11]. Furthermore, a 
suitable die-level chip detector for visible wavelengths (LA PD23HP1, Light Avenue, 
Germany) has a high radiant detection efficiency with adequate sensitivity [106]. Optical 
design feasibility was further demonstrated by Monte Carlo (MC) photon propagation 
simulations embedded in the commercially-available optical design software 
(ZEMAX® )[127] (Fig. 5.5 (a). Simulations employed performance specifications of the 
chosen components and optical tissue properties from ex vivo human tissue studies [57, 
126]. Simulations predicted that when the LED emitted 0.5 mW of angularly distributed 
power, the phototransistor detected a power of > 3 mW/cm
2
, generating a photocurrent of  
> 50 µA, which can be detected with high SNRs.  
In addition, the ZEMAX®  MC simulation results display the propagation paths of an 
individual photon that is detected by a photodetector (Fig.5.5 (b)).  The distribution of 
these paths shows an optical interrogation volume of the optoelectronic microprobe.  The 
depth of the optical sensing is approximately 500 µm. The assumption that the shape of 
this interrogation area is a hemisphere, results in a total volume of ~ 0.25 mm
3 
for this 
arrangement, which is comparable to the volume simulated with a geometry of our 
previously adoped fiber optic probe. 
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Figure 5.5 (a) ZEMAX®  Monte-Carlo simulations were employed to assess the optical 
performance of the selected LED and PD. The LED is modeled as a source with the 
parameters of intensity, angular distribution and wavelength. The PD is modeled as a 
detector with the specific active area and angular acceptance angle. Launched photons 
from the LED propagate inside tissues according to pancreas-simulating tissue optical 
properties, including scattering and absorption coefficients. The mean pathlength and 
transmission are calculated from the tissue scattering and absorption coefficients. The 
angle of each scattering step is determined by a Henyey-Greenstein phase function. 
Photons reaching the active area of the phototransistor within the acceptance angle were 
detected. (b) Photon path visulization. The simulation result displays the propagation 
paths of the photons that are detected by the photodetector. The background histology 
image of an invasive adenocacinoma has the same scale bar with the photon path image 
to represent the areas that photon paths can cover when compared to a tissue structure.  
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The feasibility of the microprobe in distinguishing three different tissue types was also 
simulated. As the inputs for bulk scattering models in ZEMAX® , the mean pathlength 
and transmission for normal pancreatic tissues, chronic pancreatitis and adenocarcinoma 
were calculated from the estimated reduced scattering coefficients and absorption 
coeffficients obtained in the previous study (Table 5.2) [68]. The LED light intensities 
were 0.6 mW and 0.5 mW for the Blue and Red LEDs, respectively, according to their 
specifications.  
The resulting intensity ratios R460/R630 of detected photons are 0.76, 0.91 and 1.21 for 
normal, chronic pancreatits and adenocarcinoma respectively. To account for the 
difference in excitation intensity of two LEDs, the ratio of adenocarcinoma is scaled 
down to 0.71 (the averaged ratio from the experiments shown in the Figure 5.1 B) which 
makes the ratio of normal tissues and chronic pancreatitis 0.44 and 0.53, respectively, 
which are consistent with the ratios obtained from the experiments. This result reveals 
that optoelectronic microprobe employing reflectance intensity ratio at specific narrow 
wavelengths has potential to differentiate adenocarcinoma from normal and chronic 
pancreatits. 
Table 5.2 Mean pathlength and transmission of three pancreatic tissue types  
 Normal Pancreas Chronic Pancreatitis Adenocarcinoma 
 460 nm 630 nm 460 nm 630 nm 460 nm 630 nm 
Mean 
Pathlength 
(1/mm) 
0.113 0.076 0.080 0.063 0.049 0.061 
Transmission 0.9933 0.9994 0.9958 0.9998 0.9974 0.9999 
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5.2.2 Engineering Analysis - Heat Simulation  
Energy dissipation resulting from conversion of electrical power to optical power in 
emitting LEDs generates heat. Ensuring that no tissue is damaged by this heat is another 
important factor to be considered while designing devices that are to be inserted into the 
human body for in vivo sensing.  
The ANSYS software is employed to simulate temparature changes around the pancreatic 
tissues when the microprobe is working. A human pancreatic head was modeled as a 
cube with an edge of 3 cm [128]. For the microprobe, two LEDs were located 1.2 mm 
apart from each other on a 150 µm-thick silicon wafer that was attached onto a steel 
stylet shaped in a half cylinder (Fig. 5.6 (a)). The properties related to heat tranfer, 
including  heat capacity, density and thermal conductivity, of the pancreatic head, silicon 
wafer and steel stylet were inputs to the model for both steady-state and time-transient 
simlulations (Table 5.3) [129-131]. Because of the symetrical structure of the model, the 
simulation was perfomed only on one half of the model. Around 230,00 nodes were used 
to analyze this model. Specially finer sized elements were meshed around LEDs and 
silicon wafer since more significnat temperature variations exist in these areas. The 
power of heat was determined by equating it to the electrical power of 10 mW, which is 
necessary to emit the required optical power of  ~ 1mW, estimated from the previous 
optical simulations. An initial temperature of the pancreas was set to 36.5 ˚C. 
Table 5.3 Hear transfer properties of three components   
 Pancreas Silicon Wafer Stylet (steel) 
Thermal Conductivity 
(W/m˚C) 0.54 130 60.5 
Heat Capacity (J/g˚C) 3.16 0.70 0.43 
Density (g/cm3) 1.09 2.33 7.85 
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Simulation results show that the maximum temperature increases up to 37.4 ˚C, a second 
after both LEDs are switched on (Fig. 5.6 (c)). One second is our expected optical 
sensing time for a real-time feedback. While the maximum temperature shown in the 
graph occurs inside the LED bodies, the maximum temperature of the surrounding 
pancreatic tissues is found to be around 37.0˚C, which shows a less than an 1˚C increase.  
Even at a time point of 10 seconds when the temperature reaches near the steady-state 
point, the maximum temperature of the model is 38.1 ˚C and the maximum tissue 
temperature is about 37. 6˚C (Fig. 5.6 (d)).  It is also noted that the area with temperature 
changes is limited to within 5 mm around the microprobe. These results demonstrate that 
the optical sensing of the microprobe would not damage assessed tissues and adjacent 
tissue area. Without the assumption of a perfect contact between LEDs and the 
surrounding tissues, indicating no thermal contact resistance, the maximum tissue 
temperature would reduce a bit more.  
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Figure 5.6 (a) 3D model of each component in the optoelectronic microprobe that affects 
heat distribution inside a tissue block ( 3 × 3 × 3 cm ) mimiking the heat properties of 
human pancreas. The LED size is 300 × 300 × 200 µm (W × D × H) and legnthes of the 
silicon board and the stylet are both 17 mm (b) A transient curve shows that the 
maximum temperature increases by time. The maximum temperature reaches the steady-
state in almost 10 second. (c) 3D temperature distribution 1 second after LED emission 
and 2D zoomed-in images of the heat distribution surrounding the microprobe. Colored 
bar indicates different temperatures for both images. (d) 3D temperature distribution 10 
seconds after LED emission and 2D zoomed-in images of the heat distribution 
surrounding the microprobe. Although the area with the increased temperature become 
wider, it is only limited to about 5 mm around the microprobe, and the maximum 
temperature occurs only inside the LED bodies and is 1.5 ˚C higher than the initial 
temperature. 
 
 
 
Time (s)
0 5 10
M
a
x
. 
T
e
m
p
e
ra
tu
re
 (
C
)
37.0
37.5
38.0
(a) (b)
(c) (d)
LEDs
Si wafer Board 
Stylet
 78 
 
5.2.3 Fabrication  
A prototype board for the optoelectronic microprobe was fabricated on a silicon wafer 
with 500 µm thickness (2 µm-thick oxide layer on the top for insulation) based on the 
well-established microfabrication procedures illustrated in Fig. 5.7. Cr/Pt/Au and In/Au 
layers were patterned by lift-off process for pad contacts of the light emitting diode 
(LED) and the photodiode (PD), and interconnections to external electrodes. Detailed 
steps are listed as follows.  
 
a) A silicon wafer with 500 µm thickness was used 
b) Photoresist (PR, SPR220 3.0, Microchem, Westborough, MA) was spin-coated and 
then patterned by a photolithography technique  
c) Cr/Pt/Au (200/300/2500Å ) were deposited onto the patterned photoresist by an 
electron beam (E-beam) evaporator (Enerjet Evaporator)  
d) Then, the PR with undesired Au/Cr layer was lifted away to leave Cr/Au pattern  
e) To bond the bottom side (Au) of the red LED (C4L 12T5, Chip4Light, Germany) and 
PD (LA PD23HP1, Light Avenue, Germany), Indium (In)-Au eutectic bonding process 
was chosen [132, 133]. Thus, In pads were defined within Cr/Au pattern by the second 
lift-off process. To pattern thick (6 µm) In pads, liftoff resist (LOR, LOR 30B, 
Microchem) was coated as an under-cut layer in a bi-layer lift-off process  
f) The PR was coated onto the LOR. PR and LOR were developed by the 
photolithography  
g) E-beam evaporator (Cooke Vacuum Products, South Norwalk, CT) deposited Au/In 
(1 nm/6 µm)  
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h) Lift-off process followed by soaking the device in the positive resist stripper (PRS 
2000, Philipsburg, NJ) in 85°C for 20 minutes and sonication until the pattern was 
completely defined  
  
 
Figure 5.7 Prototype Fabrication Process  
 
 
 
 
 
 
 
 
a) Si wafer with oxide 
b) PR development 
c) Cr/Au deposition
d) Lift off 
e) LOR and PR coating
f) LOR and PR development
g) Au/In deposition
h) Lift off
Si wafer Oxide PR Cr/Au PR LOR Au/In
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5.2.4 Assembly and Packaging  
Prior to assembly, the fabricated bare board was rinsed by being immersed in acetone for 
10 minutes and then in isopropyl alcohol (IPA) for 5 minutes.  Assembly process 
consisted of four steps (Fig.5.8 (a)) First, In-Au eutectic bonding was performed by 
employing customized recipes to bond the bottom side of PD and Red LED onto the 
defined In pads. Temperature profile was programmed to provide the optimal temperature 
in the rapid thermal process tool (Jetfirst-100, Jipelec, Montpellier, France). 250 °C was 
maintained for 5 minutes to provoke In-Au eutectic bonding. Then, since the bottom side 
metal of the blue LED die (460DA3547, Cree, Durham, NC) was Au-Sn alloy (solder), 
which was known to a eutectic alloy, the temperature was up to 280 °C in 5 second based 
on the recommended flux eutectic reflow process [134]. Higher temperatures (290°C and 
300°C) were additionally attempted to find the optical condition. Once the eutectic 
bonding was formed between Au and In, higher temperature for Au-Sn eutectic bonding 
(~ 280˚C) than the eutectic temperature for In-Au (250 °C) did not affect the bonding 
status [133]. The cathode pad on the top of the PD and Red LED were wire-bonded to the 
interconnections at the bottom of the board via 0.007 inch-thick Au wire. An optically 
transparent epoxy (NOR-61, Norland, Cranbury, NJ) encapsulated the bonded 
components (Fig. 5.8 (c)). A 30G-needle (Becton Dickinson, Franklin Lakes, NJ) 
delivered a drop of the epoxy to confine the volume covering all the three components. 
The epoxy was cured by 365 nm UV light exposure for 10 seconds.  The fabricated 
prototype board was further cut to demonstrate the size of the optoelectronic probe that 
can be compatible with the inner diameter of a 19G hollow needle in comparison with a 
US dime (Fig. 5.8 (d)). 
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Figure 5.8 (a) Assembly process. (b) Assembled LEDs and PD on a large-scale 
fabricated prototype board (c) Zoomed-in image of eutectic bonded LEDs and PD, and 
epoxy encapsulation to protect the wire bonding and components. (d) Size comparison 
between the optoelectronic microprobe and a US dime.  
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5.2.5 System Controller Design  
A custom electronic control module was designed and developed to drive two LED 
sources, read a current generated by detected photons on the PD. (Fig. 5.9) A 
microcontroller unit based on a 32-bit ARM core (ST32F405OE, STMicroelectronics, 
Geneva, Switzerland) was employed to sequence two LEDs, set the gain on a 
programmable gain amplifier (PGA), read the analog-to-digital converted (ADC) values 
and send the data to PC via a serial communication.  
A single supply low noise LED current driver was implemented by employing a current 
output digital-analog converter (AD5452, Analog Device, Norwood, MA)[135]. A trans-
impedance amplifier (TIA) was designed to convert the phototransistor current to a 
voltage signal with an amplification of 10
5
 and 1
st
 order low-pass filter characteristics 
(cut-off frequency: 1 kHz). A programmable gain amplifier (LTC6910, Linear 
Technology, Milpitas, CA) enabled an additional gain adjustment via digital control, 
providing a high dynamic range [136]. The amplified voltage was subsequently filtered to 
yield a high SNR signal. A 16-bit analog-digital-converter (ADS1115, Texas 
Instruments, Dallas, TX) read the resulting voltage at 50 kHz. 
 
Figure 5.9 A. Block diagram of the custom electronic module (GUI: graphical user 
interface, µC: microcontroller, DAC: digital-analog converter, ADC: analog-digital 
converter, LPF: low pass filter, PGA: programmable gain amplifier, TIA: Trans-
impedance amplifier) B. 3D rendered image of the designed signal conditioning module 
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5.2.6 Components Characterization  
5.2.6.1 LED Characterization  
If-Vf curves for both LEDs were obtained by adjusting the forward voltage in a 0.1 V step 
size using a digital power supply (E3631A, Keysight Technology, Santa Clara, CA), and 
recording the corresponding forward current flowing through the LEDs. For the blue 
LEDs, If-Vf curves of three different sets according to different bonding temperatures 
(280, 290 and 300 °C) were measured to find the best bonding tempereture. For the red 
LEDs, to investigate the effect of the second eutectic bonding of the blue LEDs, two sets 
of the red LEDs were measured before and after the eutectic bonding for the blue LEDs.  
Optical powers of the emitted beam were measured using an integrating sphere coupled 
with a photodetector (3A-IS-V1, Ophir-Spiricon, North Logan, UT) to account for the 
diverging emission of both LEDs. The emission wavelength was recorded by an optical 
spectrometer (HR2000, Ocean Optics). Forward voltages were also varied for each LED 
to check for potential wavelength shift.  
5.2.6.2 PD Characterization  
The linearity between the detected optical power and the PD output was assessed by 
emitting blue and red LEDs, which were characterized with If-optical power curves in the 
chapter 5.2.5.1, towards the PD at a specific distance. The blue LED was located 45 mm 
away from the PD and driven with the forward voltage varying from 2.9 V to 3.5 in 0.1 V 
step. The output voltage at the TIA coupled with the PGA was read by an oscilloscope 
(TDS220, Tektronics, Beaverton, OR). The resistance determining a gain in the TIA was 
100 K to provide the gain of 10
5
. With the gain of the PGA set to 100, the total gain of 
the system was 10
7
. The distances between PD and LEDs were determined to make the 
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output voltage swing from 0 to 5V, which was a supply voltage of the TIA and PGA. The 
red LED located 60 mm away from the PD because the sensitivity of the PD in 630 nm 
was higher than in 460 nm. The same measurement was performed on the red LEDs.     
5.2.6.3 Feasibility on Reflectance Sensing   
To test the feasibility of reflectance sensing of the fabricated prototype, optical tissue-
simulating phantoms were created. The phantoms comprised Intralipid (I141, Sigma 
Aldrich, St. Louis, MO) as a scatterer in an agar-based matrix. Specifically, a set of 
optical phantoms with three different IL concentrations (0.4, 0.8 and 1.2 mL of IL in 20 
mL of de-ionized water) were manufactured to investigate the relationship between 
scatterer concentration and detected reflectance at the given geometry and angular 
sensitivity of source and detector. The phantoms were prepared in the petri dish with a 
diameter of 60 mm and a height of 15 mm, and placed on the black holder to prevent the 
reflectance from the bottom. The prototype sensing module was placed onto the solid 
phantom and slightly pushed to make sure the LED and PD contact the surface (Fig. 
5.10). The probe interrogated three spots on the phantoms and the measured voltages 
accounted for ambient voltage background.  
 
Figure 5.10 Reflectance sensing on tissue simulating optical phantoms with (a) 460 nm 
and (b) 650 nm.  
 
(a) (b)
 85 
 
5.2.6.4 Feasibility Test for Fluorescence Sensing 
The feasibility of fluorescence sensing of the developed microprobe was assessed using 
standard fluorescence solutions. For tests, a small and thin long pass filter passing only 
fluorescence to the detector was not available. Thus, two microprobe modules were 
employed, one each for 460 nm blue LED emission and PD detection, respectively (Fig. 
5.11 (a)). The blue LED in one device excited 10 µM Rhodamine B in a cuvette with a 
1cm-pathlength, and an off-the-shelf long pass filter with a 488 nm cutting wavelength 
(FF01-488/LP, Semrock, Rochester, NY) (Fig. 5.11 (b)) blocked 460 nm excitation light 
and passed only fluorescence emission (peak emission was around 580 nm) towards the 
PD in another device. The forward voltage of the LED increased and the corresponding 
voltages on the TIA were obtained.  
 
Figure 5.11 (a) Fluorescence Measurements Setup (b) A long pass filter (LP) with 488 
nm cutting wavelength was set up very closely to the PD so that only light passed the LP 
can be detected by the PD 
 
5.3 Results  
5.3.1 Characterization of the Assembled Components 
5.3.1.1 Blue LED - Cree DA460  
460nm 
Blue LED
10 µM 
Rhodamine B
488 nm LP
PD
(a) (b)
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Figure 5.12 (a) shows If-Vf characteristics of assembled blue LEDs depending on 
different temperatures applied for the eutectic bonding process. At the temperature higher 
than 280 °C, If-Vf performance is deteriorated and inconsistent. Measured If-Optical 
power curves show a good linear relationship and consistency between three samples 
(Fig. 5. 12 (b)). Peak emission wavelength is 457 nm with a full-width-half-maximum of 
around 30 nm (Fig. 5. 12 (c)). No prominent wavelength shift depending on the forward 
voltage is observed (Fig. 5. 12 (d)).   
 
Figure 5.12 (a) Vf-If curves of bonded blue LED depending on different bonding 
temperatures (b) Measured optical power versus the forward current on three different 
samples (c) Emission spectrum depending on Vf (d) Zoomed-in spectrum at the peak 
emission wavelength  
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5.3.1.2 C4L Red LED  
The bonded red LEDs after the eutectic bonding of blue LEDs shows the same 
performance as the LEDs before the bonding (Fig. 5.13 (a)). This indicates the second 
eutectic bonding does not affect the results of the first eutectic bonding. Measured optical 
powers are proportional to the applied forward voltages with consistency between three 
samples. At a regular forward current of 50 mA, the optical power is 22.5mW. The 
measured peak emission wavelength is around 650 nm with a FWHM of 20 nm. The 
wavelength is shifted at 1/15 nm/mA rate.  
 
Figure 5.13 (a) Vf-If curves of bonded red LED before (Green) and after (Red) the 
second eutectic bonding. Each set has three samples (b) Measured optical power versus 
the forward current on three different samples (c) Emission spectrum depending on Vf (d) 
Zoomed-in spectrum at the peak emission wavelength  
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5.3.1.3 Photodiode   
Figure 5.14 displays a linear relationship between the forward current of the sources 
(optical powers detected on the PD) and detection voltage (current flowing in the PD) at 
the TIA output in two PDs at both wavelengths. Given the total gain is 10
7
, the dark 
current of the PD can be calculated as ~1V/10
7
 (A/V) = 0.1 µA. Two PDs show the 
consistent performance in the red wavelength, as indicated by the same slope only with a 
slight difference in dark voltages. However, the PD sample #2 shows a higher slope in 
the blue wavelength. 
 
Figure 5.14 Voltage at the TIA output according to the forward currents on (a) blue 
LEDs and (b) red LEDs  
 
5.3.2 Characterization of Reflectance Sensing on Tissue Simulating Phantoms  
For reflectance sensing, the total gain of TIA was set to 10
5
 and the forward currents 
were 2 mA and 6 mA for red and blue LED, respectively in order to avoid the saturation 
in the TIA output voltage by the direct detection of the emission light. With gain of 10
5
, 
the dark voltage was 0.1 mV. The voltages measured by the direct detection were 0.23 
mV in 460 nm and 0.39 mV in 650 nm, respectively. The detection voltages increased in 
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higher concentrations of Intralipid, indicating the reflectance sensing is feasible (Fig. 
5.15). Larger error bar in 460 nm sensing probably indicates that 460 nm sensing could 
be more sensitive than 650 nm sensing setup. 
 
Figure 5.15 Reflectance sensing results on optical phantom with different scatterer 
concentrations at (a) 460 nm and (b) 650 nm. Error bar presents the standard deviation.  
 
5.3.3 Fluorescence Feasibility Test  
With a total gain of 5×10
6
 and a forward current of 40 mA on blue LED, the PD detection 
voltage was 0.10 V without a fluorescence sample, close to the dark voltage of 0.09 V 
ensuring the block of 460 nm emission light by the 488 nm LP filter. When the sample is 
placed in the excitation and detection path, the fluorescence detection voltage is up to 
1.31 V (Fig. 5. 16 (a,b)).  Fluorescence detection voltage increases as the excitation 
power increases. (Fig. 5.16 (c)) 
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Figure 5.16 (a) Rhodamine B fluorescence emission excited by 460DA3547 blue LED 
(b) Oscilloscope screen shows the voltage at the TIA output increases when a cuvette 
containing 10 µM of Rhodamine B solution is placed between the blue LED and PD. (c) 
Detection voltages corresponding to different forward currents on blue LED. 
Fluorescence emission increased linearly to the excitation intensity.   
  
5.4 Conclusion 
The first prototype optoelectronic microprobe prototype was successfully fabricated and 
assembled.  Along with the characterization of optoelectronic components, the results of 
the feasibility tests on reflectance and fluorescence sensing demonstrate that the 
optoelectronic microprobe has the potential to non-invasively assess human tissues 
located at the sites with a constrained geometry.  
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Chapter 6.                                                                                                                      
Conclusion and Future Direction 
6.1 Summary and conclusions  
The primary goal of this dissertation was to develop (a) mathematical (b) computational 
and (c) instrumental tools to address technical needs to promote the clinical translation of 
quantitative tissue optical sensing.   
In Chapter 2, we developed the Direct Fit Photon Tissue Interaction (DF-PTI) model to 
rapidly and quantitatively analyze reflectance spectra obtained from human tissues.  The 
new DF-PTI model showed increased rapidity and accuracy in fitting the acquired tissue 
reflectance than the previously developed PTI model because of the adoption of a non-
linear least mean square algorithm.  Additionally, the DF-PTI model extracted the more 
numbers of biophysically-relevant parameters such as blood vessel size and nuclear 
refractive index, which are fixed in the original model, and did not require a priori 
information like “the canonical normal” to scale the spectra of unknown tissue types.  
The developed DF-PTI model was employed to assess Intraductal Papillary Mucinous 
Neoplasia (IPMN), a common precursor lesion of pancreatic cancer. With difficulties in 
data acquisition, this pilot study investigated 8 IPMN sites in the freshly excised pancreas 
specimen from 2 patients and compared the analysis results to normal and 
adenocarcinoma. The extracted parameters associated with cellular nuclear size and 
refractive index of IMPN were higher than normal and similar to those associated with 
adenocarcinoma, which is consistent with pancreatic tissue histology and the previous 
studies reporting the refractive index in neoplastic tissues.  The extracted parameters 
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associated with collagen fluorescence contribution were also higher in IPMN and 
adenocarcinoma than in normal. The higher collagen contribution was attributed to 
abundant fibrotic stroma. The results demonstrated the potential of optical spectroscopy 
coupled with an analytical model for characterizing pre-cancerous neoplasms in human 
pancreatic tissues. 
In Chapter 3, we proposed a simple and rapid scattering analysis model to evaluate the 
potential of real-time cancer detection in the pancreas using reflectance spectroscopy. 
Clinically-compatible reflectance and fluorescence spectrometer was employed to 
interrogate the freshly excised pancreas during the surgery. In total, 105 sites from 18 
patients, including 39 normal, 32 chronic pancreatitis and 34 adenocarcinoma sites, were 
analyzed. Prior to employing the scattering model, a Principal Component Analysis 
(PCA) was performed on both fluorescence and reflectance, and a tissue classification 
algorithm employing PCA parameters revealed that the reflectance-only dataset showed 
the classification performance comparable to the performance of hybrid approach 
(reflectance and fluorescence), which provide a scientific rationale for the following 
reflectance analysis.  
The simple scattering model was employed to accurately extract the reduced scattering 
coefficients and scattering power from the obtained reflectance spectra. The estimated 
reduced scattering coefficient of adenocarcinoma (10.53 ± 0.43 cm
-1
, mean ± SE) was 
statistically lower than normal (15.96 ± 0.36 cm
-1
) and chronic pancreatitis (12.66 ± 0.42 
cm
-1
), while the scattering power increased in adenocarcinoma (0.77 ± 0.05, mean ± SE), 
compared to normal (0.21 ± 0.01) and chronic pancreatitis (0.51 ± 0.06).  The 
classification algorithm employing these two scattering parameters distinguished 
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malignant tissues (adenocarcinoma) from non-malignant tissues (normal and chronic 
pancreatitis) with 94% sensitivity and 75% specificity. Because of its compact/cost-
effective instrument, rapid data acquisition and quantitative analysis, and the diagnostic 
power of scattering parameters, diffuse reflectance spectroscopy has the potential to 
become real-time optical biopsy compatible with current clinical procedures. 
In Chapter 4, we devised the Ray-Traced Monte Carlo simulation method to 
computationally model fluorescence excitation and detection by optical spectroscopy and 
imaging systems on turbid media. The RTMC combined the optical design software, 
ZEMAX®  for ray-tracing through optical systems and Monte Carlo simulation for 
modeling photon propagations inside turbid samples. The developed RTMC method was 
first verified computationally on epithelial tissue models mimicking colon cancer. The 
source-detection configurations employing fiber optic probes with flat-ended tip were 
modeled by both RTMC method and the original gold-standard MC code, and the 
simulation results were compared. The percent errors between the MC and RTMC were 
3.5 % and 7.4 % for reflectance and fluorescence, respectively. Additionally, the RTMC 
method was experimentally verified on optical phantom measurements with a depth-
sensitive fluorescence spectroscopy system. Two-layered solid phantoms were fabricated 
with a top agarose-based layer with Rhodamine 6G on top of the PDMS-based bottom 
layer with POPOP.  Depth-sensitive spectroscopy measurements were performed by 
scanning a focal point in the z-direction up to 1 mm. Top layer sensitivity was calculated 
from the measured fluorescence spectra and compared with results of the RTMC 
simulation that optically modeled phantoms and optical systems. The simulation results 
predicted the actually measurements within 15%, indicating that the RTMC was able to 
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accurately model fluorescence excitation and detection on turbid media by 
spectroscopy/imaging systems that employ complex optical components. The verification 
results suggested that the developed RTMC method has potential as an efficient and 
useful computational tool for designing or assessing fluorescence detection systems in 
turbid media.   
In Chapter 5, we designed and developed a prototype of the optoelectronic microprobe 
for volumetric optical sensing during the EUS-FNA procedure with an aim of more 
accurate diagnosis of pancreatic neoplasia. Die-level optoelectronic components (two 
LEDs at 460 nm and 650 nm and one PD) were selected to meet the mechanical, 
electrical and optical requirements.  The prototype board was fabricated based on 
standardized microfabrication technology, including photolithography and a lift-off 
process. LEDs and PD were bonded onto the fabricated board via two consecutive 
eutectic bonding processes, and wire-bonding followed to connect the top electrodes of 
the LED and PD to the bottom pads. The low-noise LED driver and trans-impedance 
amplifier coupled with the programmable gain amplifier were designed and implemented 
for controlling the optical sensing and monitoring.  
The assembled LEDs were characterized by obtaining If-Vf curves, If-Power curves and 
emission wavelength, and the PD was characterized by measuring dark current and the 
detected optical power-IPD curve, to ensure that the assembly process did not affect the 
performance of the chips. The feasibility of reflectance sensing was tested on tissue 
scattering phantoms with different concentrations of Intralipid, and the results showed a 
linear relationship between the scattering properties and the detected reflectance. For 
fluorescence, a 10 µM Rhodamine B solution was excited by the 460 nm LED and the 
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fluorescence was able to be detected by the PD coupled with a long-pass filter that cut 
excitation wavelength. These test results demonstrated that the optical sensing module 
employing micro-optoelectronic chips was feasible. Further characterization and 
upgrading of the board design to make it compatible with a 19G needle will be the next 
step for this project.    
             
The major contribution of this dissertation can be summarized as follows:  
 We developed an improved mathematical model called DF-PTI that can rapidly 
extract the parameters associated with nuclei size, refractive index, blood vessel 
size and collagen contribution in human tissues without a need of a priori 
information.    
 We reported the first-ever optical spectroscopic analysis on a precursor lesion of 
pancreatic cancer, IPMN.  
 We revealed that reflectance spectroscopy alone could be as useful as the 
multimodal approach in terms of an accurate diagnosis of pancreatic cancer, 
representing the potential of real-time optical biopsy resulting from its 
compactness, cost-effectiveness and speed of analysis.   
  We made the first estimation of the reduced scattering coefficient and scattering 
power at a specific wavelength range in human pancreatic tissues. This estimation 
was based on tissue-simulating scattering phantoms.  
 We presented the first-ever assessment of pancreatic tissue scattering properties as 
an optical biomarker for pancreatic cancer diagnosis by employing a novel tissue 
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classification algorithm constructed with GEE that accounts for he intra-patient 
correlation.  
 We created the first-ever ray-traced Monte Carlo (RTMC) computational method 
to model a complete ray path on fluorescence excitation and detection in turbid 
media.  
 We manufactured the first two-layered optical phantom, in which both layers are 
solid; an agar-based top layer containing Rhodamine 6G and Intralipid and a 
PDMS-based bottom layer mixed with titanium oxide and POPOP. This phantom 
required no additional sheet which could potentially have an unknown impact on 
the optical measurement between the two layers because of the hydrophilic and 
hydrophobic properties of top and bottom layer, respectively.  
 We designed and developed the first-ever prototype of an optoelectronic 
microprobe including micro-sized die-level chip LEDs and PD, which will fit 
within a 19G hollow needle and potentially provide the flexibility of source-
detector configurations for adjustment of optical interrogation volumes.          
 We evaluated the performance of assembled components in the prototype, and 
tested the feasibility of reflectance sensing on tissue-simulating scattering 
phantoms and fluorescence sensing on standard fluorophores.  
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6.2 Future Research Direction  
6.2.1 Optical Detection of Pancreatic Cancer   
The reflectance spectroscopic technique reported in Chapter 2 and 3 is potentially 
compatible with the current EUS-FNA procedure. FNA-needle compatible fiber-optic 
spectroscopy has been demonstrated to be capable of characterizing lymph node 
physiology in vivo [36, 67]. A single channel fiber optic (600 µm) was employed in this 
study coupled with a mathematical model to evaluate physiological parameters related to 
blood content. Although the same dimension of optical fiber with the mathematical 
model may possibly be employed for future in vivo pancreas studies, a dual channel with 
smaller diameter (~ 300 µm) would also appear to be feasible, considering the internal 
diameter of conventional FNA needles.    
Because of its great classification performance for distinguishing adenocarcinoma sites 
from normal tissues, (sensitivity 94% and specificity 95%), reflectance spectroscopy can 
be employed for surgical margin detection during the surgery. The rapid acquisition and 
analysis of one reflectance spectrum could potentially enable an advanced design for a 
scattering imaging system by incorporating 2-dimensional scanning in order to provide 
spatial information [137]. 
6.2.2 Ray-Traced Monte Carlo Simulation  
Upgrade for time-resolved fluorescence model  
The current RTMC method enables steady-state fluorescence only simulations. However, 
time-resolved fluorescence simulation could be achieved by adopting lifetime 
determination methods commonly employed for a time-gated fluorescence lifetime 
imaging (FLIM) system. Inside the current MC codes, an internal function records the 
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traveling time of each individual fluorescence photons. A virtual gating could be 
implemented in the code to collect all the fluorescence photons exiting the sample surface 
within a specific time range and then export them as one geometrical distribution file that 
can be fed into a ZEMAX®  detection model. For the four-gate model, four geometrical 
distribution files will be generated, and the ZEMAX®  detection model will run four 
times with the corresponding distribution files as a source, resulting in the simulated 
gated-fluorescence intensity. A ZEMAX®  macro program could automate this repetitive 
process. The four intensity values detected by ZEMAX®  would be employed in an 
analytical least square lifetime determination based on equation 6. 1 
2 2( ) ( )
ln ( )( ln )
i i
i i i i
N t t
N t I t I


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
 
                           Equation 6.1 
where τ is the lifetime, Ii is the gated intensity at the gate i, ti is the gate delay of the gate 
i, and N is the number of gates. All sums are over i.  
Further Validation of the design of a confocal fluorescence probe in the Tissue 
Engineering Field  
To evaluate the applicability of the developed RTMC method, it could be validated on 
the design of a confocal fluorescence probe to assess the viability of manufactured tissue-
engineered constructs for oral or skin grafts in functional tissue recovery. The viability 
can be assessed by measurement of the endogenous fluorescence of metabolic co-factors 
such as NAD(P)H and FAD. However, selectively measuring the fluorescence from the 
thin cell layer is very challenging to because of high scattering in the top keratin layer 
and the abundant collagen fluorescence from a bottom dermal equivalent of the 
constructs. Compared to previously implemented fiber-optic system, the confocal 
 101 
 
fluorescence probe is capable of finer resolution depth-sectioning that effectively 
suppresses the strong keratin and collagen fluorescence and extracts only the epithelial 
fluorescence.  
An example of the preliminary design is shown as Figure 6.1.All the selected lenses are 
commercially-available and have small footprints (diameter < 5 mm), which would 
enable a future probe to access the various human sites. RTMC simulation could be 
employed to determine the optimal design parameters.  The optical probe system could be 
modeled in the non-sequential mode of ZEMAX®  and fluorescence emission and 
propagation inside the constructs could be simulated via MC codes based on the optical 
properties of the constructs. 
 
 
Figure 6.1 (a) Optical ray trace of the preliminary design of the future hand-held probe 
for non-invasive sensing of implanted tissue-engineered constructs in human. An 
aspherical lens was employed for an objective lens and two achromatic lenses for higher 
resolution via further magnification without chromatic aberration. (b) Design of non-
miniaturized proof-of-concept system proposed here, based on 30 mm- cage optical 
mounts. Model names for commercially-available lenses and mounts are labeled
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6.2.3 Optoelectronic Microprobe 
2
nd
 Prototype Design and Fabrication 
The next version of the prototype will have a physical dimension that fits within the inner 
diameter of a 19G needle (~850 µm). While the current prototype was developed on 500 
µm-thick wafer, the bottom side of the next version could be etched to a ~ 100 µm for 
needle integration. Relative position of two LEDs to PD could be changed to increase an 
overlapping area of the optical detection path of each source-detection module. In the 
current version, the blue LED is located on the other side across the PD, which separates 
optical detection path of two LEDs (Fig 6.2 (a)). The red LED could be located on the 
other side of Blue LED as shown in Fig. 6.2 (b). The effect of a prolonged optical path 
for the red LED (> 600 µm) could be simulated by the developed RTMC simulation.        
 
Figure 6.2 (a) Current configuration of the PD and LEDs in the prototype assumes the 
homogeneity of the sample (~ 1mm
3
) interrogated by optical path (which is shaped like 
“banana pattern”) of detected photons in each Blue LED-PD and Red LED-PD module 
although each path separates. The optical sampling volume is comparable to a biopsy 
volume acquired by EUS-FAN procedure. (a) However, if Red LED is moved to the next 
to Blue LED, the interrogation volume could be reduced and overlapping area of the 
optical path could increase, thus increasing the overall resolution of optical sensing.   
 
 
(a) (b)
Blue LED PD Red LED
Sampling 
volume
2 mm 1.5 mm
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In vivo Validation on Mouse Model  
Once the second prototype is developed and fully verified, the prototype could be 
integrated with the 19G needle (EchoTip ProCore
TM
 19G, Cook Medical) and tested on in 
vivo mouse model. Since the measured reflectance from human pancreatic xenografts in 
mice with immunodeficiency showed the similarity of human study [55], the same 
xenograft model could be employed. Genetically-engineered mouse model [138] 
mimicking pancreatic tumorigensis developed by Magliano Group in the University of 
Michigan could help to investigate the potential of microprobe in staging the 
carcinogenesis, as well as the effect of fibroinflammatory stroma along with changes in 
cellular structures of pancreatic tissues.  
Quantification on Quasi-Spectral Sensing  
Besides a simple ratio metric the current prototype can provide as diagnostic parameter, 
adding more LEDs with different wavelengths could enable a quantitative analysis based 
on quasi-spectral information. In our preliminary study, mathematical models on human 
pancreatic reflectance spectra with only four wavelengths could extract almost the same 
scattering parameters with the ones from full-wavelength spectrum (176 discrete 
wavelengths). The optimal selection of those wavelength and arrangement of each LED 
will need to be further investigated.   
Realization of fluorescence sensing  
To realize fluorescence sensing in the microprobe, a micro-sized long-pass filter must be 
fabricated. The feasibility of fabrication has been demonstrated by staking layers of TiO2 
and SiO2 based on Fabri-Perot thin-film optical resonator [139]. The performance (e.g. 
quantum yield and low dark current) of the current silicon photodiode will need to be 
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more thoroughly evaluated that it is capable of high-SNR fluorescence measurements. 
Alternatively, a silicon photo-multiplier [140] could be employed if the dimension is 
compatible with a needle.  
Testing Mechanical Integrity 
A mechanical break down of the microprobe during the procedure will cause a serious 
problem to the patient. Thus, a complete packaging of the device is essential and 
thorough mechanical tests must be performed prior to being inserted inside the needle for 
in vivo measurements. In particular, the fabricated microprobe must endure the acute 
curvature that the end of an endoscope and a needle elevation form together to reach the 
pancreas. To test the mechanical integrity of the fabricated microprobe, the Erlangen 
Active Simulator for Interventional Endoscopy (EASIE™), a clinical endoscopic training 
simulator will be employed (Fig. 6.3). The FNA hollow needle, containing the 
microprobe, will be inserted through the instrument channel of the endoscope, protruded 
through the swine stomach, and into the pancreas-simulating phantom. The microprobe 
will be removed from the endoscope and reinserted. Optoelectronic performance will be 
assessed by acquiring optical data pre- and post-insertion. Mechanical integrity will be 
verified via microscopic visual examination and electronic testing. 
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Figure 6.3 Erlanger Active Simulator for Interventional Endoscopy (EASIE™). 
Mechanical performance of the miniaturized optoelectronic probe will be validated by 
passing a needle containing the microprobe through the working channel of an EUS 
scope, placed into the model stomach to simulate the human procedure. Once the EUS 
scope is within the stomach, a tissue-simulating phantom will be placed in the position of 
the pancreas outside the stomach to validate the optical performance when the needle is 
manipulated as in the clinical exam [141] The FNA needle with microprobe will be 
protruded into the phantom for measurements; baseline measurements will be acquired 
immediately prior to the procedure.  Measurements will occur from both optical modules 
at 5 locations in the homogeneous phantom, yielding ten optical measurements. 
Measurements will be compared to each other and baselines. 
 
In case that a continuous or chronic monitoring is necessary, hermetic sealing can be 
carried out to provide superior integrity and protection against the device degradation. A 
glass cap would be bonded on the Indium pattern surrounding the optoelectronic 
components using a proper temperature and pressure [142].   
 
 
 
 
Entry Point of 
Endoscope
Swine
Stomach
Translate EUS FNA Probe Here 
-> Needle with Optics Extended 
Into a Tissue-Simulating Phantom
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